NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|82011698|sp|Q8BB25|]
View 

RecName: Full=Spike glycoprotein; Short=S glycoprotein; AltName: Full=E2; AltName: Full=Peplomer protein; Contains: RecName: Full=Spike protein S1; Contains: RecName: Full=Spike protein S2; Contains: RecName: Full=Spike protein S2'; Flags: Precursor

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
HKU1-CoV-like_Spike_SD1-2_S1-S2_S2 cd22380
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
622-1283 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from human HKU1 and OC43 coronaviruses and related betacoronaviruses in the A lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the embecovirus subgenus (A lineage), including highly pathogenic human coronaviruses (CoVs), HKU1 and OC43 CoVs, as well as murine hepatitis virus (MHV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of MHV is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


:

Pssm-ID: 411967 [Multi-domain]  Cd Length: 663  Bit Score: 1357.14  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  622 LYGITGQGILIEVNATYYNSWQNLLYDSSGNLYGFRDYLSNRTFLIRSCYSGRVSAVFHANSSEPALMFRNLKCSHVFNN 701
Cdd:cd22380    1 LYGITGQGIFKEVNADYYNSWQNLLYDSNGNLYGFRDYLTNKTYMIRSCYSGRVSAAFHANASEPALLYRNLKCSYVFNN 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  702 TILRQIQLVNYFDSYLGCVVNAYNNTASAVSTCDLTVGSGYCVDYVTALRSRRSFTTGYRFTNFEPFAANLVNDSIEPVG 781
Cdd:cd22380   81 TISREEQPLNYFDSYLGCVVNADNSTSSAVQTCDLRMGSGYCVDYSTSRRSRRSISTGYRFTTFEPFTVNLVNDSVEPVG 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  782 GLYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQLQVANSLMN 861
Cdd:cd22380  161 GLYEIQIPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILNEVNELLDTTQLQVANSLMQ 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  862 GVTLSTKIKDGINFNVDDINFSPVLGCLGSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAEIRDLICVQSYNG 941
Cdd:cd22380  241 GVTLSSRLKDGINFNVDDINFSPVLGCLGSDCNAASSRSAIEDLLFDKVKLSDVGFVEAYNNCTGGAEIRDLLCVQSFNG 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  942 IKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDAT 1021
Cdd:cd22380  321 IKVLPPVLSENQISGYTTAATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAIQEGFDAT 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1022 NSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFS 1101
Cdd:cd22380  401 NSALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGRLTALNAYVSQQLSDSTLVKFS 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1102 AAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPKSGYFINVNN 1181
Cdd:cd22380  481 AAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPGLCIAGDRGIAPKSGYFVNVNN 560
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1182 SWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVAPDLSLD-YINVTFLDLQ 1260
Cdd:cd22380  561 EWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELDQWFKNQTSVAPDLSLDeYINVTFLDLQ 640
                        650       660
                 ....*....|....*....|...
gi 82011698 1261 DEMNRLQEAIKVLNQSYINLKDI 1283
Cdd:cd22380  641 DEMNRIQEAIKVLNESYINLKEI 663
HEV_Spike_S1_RBD cd21508
receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine ...
311-608 0e+00

receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine hemagglutinating encephalomyelitis virus; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from porcine hemagglutinating encephalomyelitis virus (HEV), which is associated with acute outbreaks of wasting and encephalitis in nursing piglets from pig farms. Porcine HEV is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. The protein receptor for porcine HEV has not yet been identified. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


:

Pssm-ID: 394835  Cd Length: 298  Bit Score: 636.01  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21508    1 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYS 470
Cdd:cd21508   81 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYS 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  471 QQCFNTPNTYCPCRTSQCIGGAGTGTCPVGTTVRKCFAAVTKATKCTCWCQPDPSTYKGVNAWTCPQSKVSIQPGQHCPG 550
Cdd:cd21508  161 QQCFNTPNTYCPCRTSQCIGGAGTGTCPVGTTVRKCFAAVTNATKCTCWCQPDPSTYKGVNAWTCPQSKVSIQPGQHCPG 240
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 82011698  551 LGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 608
Cdd:cd21508  241 LGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 298
MHV-like_Spike_S1_NTD cd21625
N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and ...
16-298 0e+00

N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and related betacoronaviruses in the A lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the embecovirus subgenera (A lineage), including murine hepatitis virus (MHV), human coronavirus (HCoV) HKU1 and OC43, and bovine CoV (BCoV). MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract, while HCoV-HKU1 causes mild yet prevalent respiratory disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While most CoVs, including SARS-CoV and MERS-CoV use the C-domain to bind their receptors, several CoVs in the A lineage use the NTD to bind their receptors. MHV binds its protein receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a), through its S1 NTD. BCoV and HCoV-OC43 recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


:

Pssm-ID: 394951  Cd Length: 284  Bit Score: 577.42  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   16 IGDLKCTTSLINDVDTGVPSISSEVVDVTNGLGTFYVLDRVYLNTTLLLNGYYPISGATFRNMALKGTRLLSTLWFKPPF 95
Cdd:cd21625    1 IGDFKCTTVSINDVNTGAPSISTETVDVSNGLGTYYVLDRVYLNTTLLLNGYYPTSGSTYRNLALKGTLLLSTLWFKPPF 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   96 LSPFNDGIFAKVKNSRFSKDGVIYSEFPAITIGSTFVNTSYSIVVEPHTSLINGNLQGLLQISVCQYTMCEYPHTICHPN 175
Cdd:cd21625   81 LSEFNNGIFAKVKNTKVSKNGVMYSEFPTIVIGSTFVNTSYTVVVQPHTGNSDNKLQGILEISVCQYTMCEYPNTICKPN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  176 LGNQRIELWHYDTDVVSCLYRRNFTYDVNADYLYFHFYQEGGTFYAYFTDTGFVTKFLFKLYLGTVLSHYYVMPLTCNS- 254
Cdd:cd21625  161 LGNQRIELWHTDTGVPSCLYKRNFTYDVNADWLYFHFYQEGGTFYAYYADTGSVTTFLFSVYLGTVLSHYYVMPLTCNSt 240
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....
gi 82011698  255 ALSLEYWVTPLTTRQFLLAFDQDGVLYHAVDCASDFMSEIMCKT 298
Cdd:cd21625  241 ALTLEYWVTPLTKRQYLLAFNQDGVITNAVDCASDFMSEIKCKT 284
 
Name Accession Description Interval E-value
HKU1-CoV-like_Spike_SD1-2_S1-S2_S2 cd22380
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
622-1283 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from human HKU1 and OC43 coronaviruses and related betacoronaviruses in the A lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the embecovirus subgenus (A lineage), including highly pathogenic human coronaviruses (CoVs), HKU1 and OC43 CoVs, as well as murine hepatitis virus (MHV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of MHV is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411967 [Multi-domain]  Cd Length: 663  Bit Score: 1357.14  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  622 LYGITGQGILIEVNATYYNSWQNLLYDSSGNLYGFRDYLSNRTFLIRSCYSGRVSAVFHANSSEPALMFRNLKCSHVFNN 701
Cdd:cd22380    1 LYGITGQGIFKEVNADYYNSWQNLLYDSNGNLYGFRDYLTNKTYMIRSCYSGRVSAAFHANASEPALLYRNLKCSYVFNN 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  702 TILRQIQLVNYFDSYLGCVVNAYNNTASAVSTCDLTVGSGYCVDYVTALRSRRSFTTGYRFTNFEPFAANLVNDSIEPVG 781
Cdd:cd22380   81 TISREEQPLNYFDSYLGCVVNADNSTSSAVQTCDLRMGSGYCVDYSTSRRSRRSISTGYRFTTFEPFTVNLVNDSVEPVG 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  782 GLYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQLQVANSLMN 861
Cdd:cd22380  161 GLYEIQIPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILNEVNELLDTTQLQVANSLMQ 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  862 GVTLSTKIKDGINFNVDDINFSPVLGCLGSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAEIRDLICVQSYNG 941
Cdd:cd22380  241 GVTLSSRLKDGINFNVDDINFSPVLGCLGSDCNAASSRSAIEDLLFDKVKLSDVGFVEAYNNCTGGAEIRDLLCVQSFNG 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  942 IKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDAT 1021
Cdd:cd22380  321 IKVLPPVLSENQISGYTTAATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAIQEGFDAT 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1022 NSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFS 1101
Cdd:cd22380  401 NSALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGRLTALNAYVSQQLSDSTLVKFS 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1102 AAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPKSGYFINVNN 1181
Cdd:cd22380  481 AAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPGLCIAGDRGIAPKSGYFVNVNN 560
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1182 SWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVAPDLSLD-YINVTFLDLQ 1260
Cdd:cd22380  561 EWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELDQWFKNQTSVAPDLSLDeYINVTFLDLQ 640
                        650       660
                 ....*....|....*....|...
gi 82011698 1261 DEMNRLQEAIKVLNQSYINLKDI 1283
Cdd:cd22380  641 DEMNRIQEAIKVLNESYINLKEI 663
CoV_S2 pfam01601
Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic ...
784-1291 0e+00

Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic 'corona' after which the group is named. The Spike glycoprotein is translated as a large polypeptide that is subsequently cleaved to S1 pfam01600 and S2,. The S2 subunit normally contains multiple key components, including one or more fusion peptides (FP), a second proteolytic site (S2') and two conserved heptad repeats (HRs), driving membrane penetration and virus-cell fusion. The HRs can trimerize into a coiled-coil structure built of three HR1-HR2 helical hairpins presenting as a canonical six-helix bundle and drag the virus envelope and the host cell bilayer into close proximity, preparing for fusion to occur.


Pssm-ID: 460263  Cd Length: 502  Bit Score: 726.37  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    784 YEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQLQVANSLMNGV 863
Cdd:pfam01601    1 GNISIPTNFTISVQTEYIQTTSPKVSVDCAQYVCNGNERCLQLLVQYGSFCSTIEQALQGSARLEDVEVLSMLSISNRAL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    864 TLSTKIKDGINFNvddinFSPVLGCLGSecnrasTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAEIRDLICVQSYNGIK 943
Cdd:pfam01601   81 TLATISNFGSDFN-----FSSFLPCLNS------GRSAIEDLLFDKVVTSGLGTVDAYKKCTKGTSIADLVCAQYYNGIM 149
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    944 VLPPLLSENQISGYTLAATAASLFPPWT-AAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDATN 1022
Cdd:pfam01601  150 VLPGVVDAEKMAMYTASLTGGMAFGGLTgAAAAIPFALAVQARLNYLGLQTDVLQENQKILANAFNNAVGNITDGFTTTA 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   1023 SALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSA 1102
Cdd:pfam01601  230 SALSKIQDVVNANAQALNQLTQQLSNNFGAISSSIQDIYSRLDQLEADAQVDRLINGRLAALNAFVTQQLTKASEVKASR 309
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   1103 AQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPKSGYFINVNNS 1182
Cdd:pfam01601  310 QLAQQKVNECVKSQSSRYGFCGNGTHLFSLPQAAPNGIMFLHTVLVPTEYITVKATPGLCVNGTTGYAPRDGQFVLNNTS 389
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   1183 -WMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVAPDLSLDYINVTFLDLQD 1261
Cdd:pfam01601  390 nWYITPRNMYQPRPITGSDFVQISSCDVNFVNITNTKLPPLIPDYVDFNKELEDIYKNLNSTLPDLDLDIFNATILNLTD 469
                          490       500       510
                   ....*....|....*....|....*....|...
gi 82011698   1262 EMN---RLQEAIKVLNQSYINLKDIGTYEYYVK 1291
Cdd:pfam01601  470 EIKdleRLQELIDNLNQTLVDLEWLNRYETYIK 502
HEV_Spike_S1_RBD cd21508
receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine ...
311-608 0e+00

receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine hemagglutinating encephalomyelitis virus; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from porcine hemagglutinating encephalomyelitis virus (HEV), which is associated with acute outbreaks of wasting and encephalitis in nursing piglets from pig farms. Porcine HEV is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. The protein receptor for porcine HEV has not yet been identified. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394835  Cd Length: 298  Bit Score: 636.01  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21508    1 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYS 470
Cdd:cd21508   81 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYS 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  471 QQCFNTPNTYCPCRTSQCIGGAGTGTCPVGTTVRKCFAAVTKATKCTCWCQPDPSTYKGVNAWTCPQSKVSIQPGQHCPG 550
Cdd:cd21508  161 QQCFNTPNTYCPCRTSQCIGGAGTGTCPVGTTVRKCFAAVTNATKCTCWCQPDPSTYKGVNAWTCPQSKVSIQPGQHCPG 240
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 82011698  551 LGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 608
Cdd:cd21508  241 LGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 298
MHV-like_Spike_S1_NTD cd21625
N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and ...
16-298 0e+00

N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and related betacoronaviruses in the A lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the embecovirus subgenera (A lineage), including murine hepatitis virus (MHV), human coronavirus (HCoV) HKU1 and OC43, and bovine CoV (BCoV). MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract, while HCoV-HKU1 causes mild yet prevalent respiratory disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While most CoVs, including SARS-CoV and MERS-CoV use the C-domain to bind their receptors, several CoVs in the A lineage use the NTD to bind their receptors. MHV binds its protein receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a), through its S1 NTD. BCoV and HCoV-OC43 recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394951  Cd Length: 284  Bit Score: 577.42  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   16 IGDLKCTTSLINDVDTGVPSISSEVVDVTNGLGTFYVLDRVYLNTTLLLNGYYPISGATFRNMALKGTRLLSTLWFKPPF 95
Cdd:cd21625    1 IGDFKCTTVSINDVNTGAPSISTETVDVSNGLGTYYVLDRVYLNTTLLLNGYYPTSGSTYRNLALKGTLLLSTLWFKPPF 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   96 LSPFNDGIFAKVKNSRFSKDGVIYSEFPAITIGSTFVNTSYSIVVEPHTSLINGNLQGLLQISVCQYTMCEYPHTICHPN 175
Cdd:cd21625   81 LSEFNNGIFAKVKNTKVSKNGVMYSEFPTIVIGSTFVNTSYTVVVQPHTGNSDNKLQGILEISVCQYTMCEYPNTICKPN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  176 LGNQRIELWHYDTDVVSCLYRRNFTYDVNADYLYFHFYQEGGTFYAYFTDTGFVTKFLFKLYLGTVLSHYYVMPLTCNS- 254
Cdd:cd21625  161 LGNQRIELWHTDTGVPSCLYKRNFTYDVNADWLYFHFYQEGGTFYAYYADTGSVTTFLFSVYLGTVLSHYYVMPLTCNSt 240
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....
gi 82011698  255 ALSLEYWVTPLTTRQFLLAFDQDGVLYHAVDCASDFMSEIMCKT 298
Cdd:cd21625  241 ALTLEYWVTPLTKRQYLLAFNQDGVITNAVDCASDFMSEIKCKT 284
bCoV_S1_N pfam16451
Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal ...
42-330 9.84e-83

Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal domain of the betacoronavirus-like trimeric spike glycoprotein. The distal S1 subunit of the coronavirus spike protein is responsible for receptor binding. S1 contains two domains; an N-terminal galectin-like domain (NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Either the S1 NTD or S1 RBD, or occasionally both, are involved in binding to host receptors. S1 NTD is located on the side of the spike trimer and mainly recognizes sugar receptors. For many betacoronaviruses (b-CoVs), for example mouse hepatitis virus (MHV), the RBD is located in the NTD. The structure of the MHV S1 NTD showed the same fold as human galectins (galactose-binding lectin), however it does not bind any sugar; instead, it binds to the carcinoembryonic antigen cell-adhesion molecule CEACAM1) through protein-protein interactions. All three CEACAM21a-binding sites in MHV spikes can be fully occupied by CEACAM1a. It has been shown that CEACAM1a binding to the MHV spike weakens the interactions between S1 and S2 and facilitates the proteolysis of the spike protein and dissociation of S1. The homologous bovine CoV (BCov) S1 NTD also possesses a galectin fold but binds to sialic acid-containing moieties on host cell membranes, as does the NTD of three other group A b-Covs, namely human CoV (HCoV) OC43, avian b-CoV, and infectious bronchitis virus (IBV). Despite the S1 NTD of human respiratory b-CoV HKU1 being highly homologous to the NTDs of MHV and bovine CoV, it does not bind to either sugar or human carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) and the RBD is found instead in the S1 RBD domain.


Pssm-ID: 465119  Cd Length: 296  Bit Score: 273.13  E-value: 9.84e-83
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698     42 DVTNGLGTFYVLDRVYLNTTLLLNGYYPISGATFRNMALKGTRLLSTLWFKPPFLsPFNDGIFAKVKNSRFSKDGVIYSE 121
Cdd:pfam16451    1 DVSKADGTYYLPDRVYSNTTTLRQGLFPKQGDNVTNYVYSPAHHCGKRNFSTPFL-PFGDGIFVHIGNASNATGGRIISE 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    122 FPAITIGSTFVNTSYSIVVEPhtslinGNLQGLLQISVCQYTMCEYPHTICHPNLGNQRIE-LWHYDTDVVSCLYRRNFT 200
Cdd:pfam16451   80 PPAFVFGSTFGNTSHTLIIAP------DSCQTNLTILVCNFTLCANPVTACRWGAGNYNANnSLVYFKNAINCTFNRTYN 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    201 YDVNADYLYFHFYQEGGTFYAYFT------DTGFVTKFLF-KLYLGTVLSHYYVMPLTCNSA-----LSLEYWVTPLTTR 268
Cdd:pfam16451  154 ITFDTSLIYFGFKQQDGGFHIYYSywlpdlDSGPPTLFPFaTLPLGINITYFQVIPSSIRSTqncrrANAAYYVAPLKPS 233
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 82011698    269 QFLLAFDQDGVLYHAVDCASDFMSEIMCKTSSITPPTGVYELNGYTVQPVATVYRRIPDLPN 330
Cdd:pfam16451  234 TFLLDFDVNGYITNAVDCSFDPLSELKCSTGSFEPDTGVYSTSSYRAQPVGSVYVRQPNVTC 295
bCoV_S1_RBD pfam09408
Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor ...
344-484 1.08e-37

Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor binding domain (S1 RBD) of the betacoronavirus spike glycoprotein. The spike glycoprotein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. SARS-CoV makes use of its S1 RBD to bind to the human angiotensin-converting enzyme 2 (ACE2) as its host receptor.


Pssm-ID: 462789  Cd Length: 156  Bit Score: 138.79  E-value: 1.08e-37
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    344 SPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTA 423
Cdd:pfam09408    2 SPANWERKTFSNCNFDFSVLLSLLQVSSFKCYGVSPSKLADMCYGSVTIDYFAIPETHKSNLQPGSPGAISKYNYKLPDD 81
                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 82011698    424 VSSCQLyyslpaanvsvtHYNPSSWNrRYGFNNQSFGSrglhdavysqqcFNTPNTYCPCR 484
Cdd:pfam09408   82 FYGCVL------------AFNVNANT-NYAFADNYPYR------------YIKPGQYQPCN 117
COG4192 COG4192
Signal transduction histidine kinase regulating phosphoglycerate transport system [Signal ...
998-1106 7.53e-03

Signal transduction histidine kinase regulating phosphoglycerate transport system [Signal transduction mechanisms];


Pssm-ID: 443346 [Multi-domain]  Cd Length: 640  Bit Score: 40.83  E-value: 7.53e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  998 QNQKLIASAFNNALDAIQEgFDATNSALVKIQAVVNANAEALNNLLQQLS----NRFgAISASLQEILSRLDAL------ 1067
Cdd:COG4192   81 TERSQLRNQLNTQLADIEE-LLAELEQLTQDAGDLRAAVADLRNLLQQLDslltQRI-ALRRRLQELLEQINWLhqdfns 158
                         90       100       110
                 ....*....|....*....|....*....|....*....
gi 82011698 1068 EAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAI 1106
Cdd:COG4192  159 ELTPLLQEASWQQTRLLDSVETTESLRNLQNELQLLLRL 197
 
Name Accession Description Interval E-value
HKU1-CoV-like_Spike_SD1-2_S1-S2_S2 cd22380
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
622-1283 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from human HKU1 and OC43 coronaviruses and related betacoronaviruses in the A lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the embecovirus subgenus (A lineage), including highly pathogenic human coronaviruses (CoVs), HKU1 and OC43 CoVs, as well as murine hepatitis virus (MHV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of MHV is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411967 [Multi-domain]  Cd Length: 663  Bit Score: 1357.14  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  622 LYGITGQGILIEVNATYYNSWQNLLYDSSGNLYGFRDYLSNRTFLIRSCYSGRVSAVFHANSSEPALMFRNLKCSHVFNN 701
Cdd:cd22380    1 LYGITGQGIFKEVNADYYNSWQNLLYDSNGNLYGFRDYLTNKTYMIRSCYSGRVSAAFHANASEPALLYRNLKCSYVFNN 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  702 TILRQIQLVNYFDSYLGCVVNAYNNTASAVSTCDLTVGSGYCVDYVTALRSRRSFTTGYRFTNFEPFAANLVNDSIEPVG 781
Cdd:cd22380   81 TISREEQPLNYFDSYLGCVVNADNSTSSAVQTCDLRMGSGYCVDYSTSRRSRRSISTGYRFTTFEPFTVNLVNDSVEPVG 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  782 GLYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQLQVANSLMN 861
Cdd:cd22380  161 GLYEIQIPTNFTIGNHEEFIQTSSPKVTIDCAAFVCGDYAACRQQLVEYGSFCDNINAILNEVNELLDTTQLQVANSLMQ 240
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  862 GVTLSTKIKDGINFNVDDINFSPVLGCLGSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAEIRDLICVQSYNG 941
Cdd:cd22380  241 GVTLSSRLKDGINFNVDDINFSPVLGCLGSDCNAASSRSAIEDLLFDKVKLSDVGFVEAYNNCTGGAEIRDLLCVQSFNG 320
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  942 IKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDAT 1021
Cdd:cd22380  321 IKVLPPVLSENQISGYTTAATAASLFPPWSAAAGVPFSLNVQYRINGLGVTMDVLSQNQKLIANAFNNALGAIQEGFDAT 400
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1022 NSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFS 1101
Cdd:cd22380  401 NSALAKIQSVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAQAQIDRLINGRLTALNAYVSQQLSDSTLVKFS 480
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1102 AAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPKSGYFINVNN 1181
Cdd:cd22380  481 AAQAIEKVNECVKSQSPRINFCGNGNHILSLVQNAPYGLYFIHFSYVPTSFVTAKVSPGLCIAGDRGIAPKSGYFVNVNN 560
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1182 SWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVAPDLSLD-YINVTFLDLQ 1260
Cdd:cd22380  561 EWMFTGSGYYYPEPITDKNVVVMSSCAVNYTKAPDVMLNTSIPNLPDFKEELDQWFKNQTSVAPDLSLDeYINVTFLDLQ 640
                        650       660
                 ....*....|....*....|...
gi 82011698 1261 DEMNRLQEAIKVLNQSYINLKDI 1283
Cdd:cd22380  641 DEMNRIQEAIKVLNESYINLKEI 663
betaCoV_Spike_SD1-2_S1-S2_S2 cd22370
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
622-1281 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses; This family contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses, including three highly pathogenic human coronaviruses (CoVs), Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411957 [Multi-domain]  Cd Length: 667  Bit Score: 871.42  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  622 LYGITGQGILIEVNATYYNsWQNLLYDSSGNLYGFRDYLSNRTFLIRSCYSGRVSAVFHANSS-EPALMFRNLKCSHVFN 700
Cdd:cd22370    1 LYGYTGTGVLTETNATFLP-FQNFGYDSNGNLIAFKDPQTNTIYTILPCVSGPVSVITPGNNTnEVAVLYNGLNCSEVPS 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  701 NtiLRQIQLV----------NYFDSYLGCVVNAYNNTASaVSTCDLTVGSGYCVDYVT--ALRSRRSFTTGYRFTNFEPF 768
Cdd:cd22370   80 A--ISAVSLTpwwrvysstsNYFDTPVGCLLGAVNSSNN-SYECDLPLGAGLCASYTTqsVLRSRSVASRSIRLTTMSFF 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  769 AANLVNDSIepVGGLYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELL 848
Cdd:cd22370  157 AENSVDVEV--AYSNFSIQIPTNFTIAVTEEFIPTTMPKVTVDCAQYVCGDSSECSNLLLQYGTFCDNINRALTGVALLQ 234
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  849 DTTQLQVANSLMNGVTLSTKIKDginfnVDDINFSPVLGCLGSECNRaSTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGA 928
Cdd:cd22370  235 DKNQLEVFASVKQIVKTPAPLKD-----FGGFNFSSLLPCLGSNGGS-SARSAIEDLLFNKVTLADVGFMKQYDDCTGGS 308
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  929 EIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFP----PWTAAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIA 1004
Cdd:cd22370  309 AARDLICAQSFNGLKVLPPLLTDEMIAAYTSALLGGTATSgwtfGASSAAQIPFAMQMAYRFNGIGVTQQVLVENQKLIA 388
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1005 SAFNNALDAIQEGFDATNSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTAL 1084
Cdd:cd22370  389 NKFNQALGSIQTGFTATNSALAKLQDVVNQNAQALNTLVKQLSNNFGAISSSLNDILSRLDKLEADVQIDRLINGRLQVL 468
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1085 NAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIA 1164
Cdd:cd22370  469 QTYVTQQLIRASEIRASAQLAAQKMSECVKGQSKRVDFCGNGTHLMSFPQSAPNGVVFLHVTYKPTSYKNVTTAPAICHN 548
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1165 GDIGIsPKSGYFINVNNSWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVA 1244
Cdd:cd22370  549 GKAYF-PKEGVFVKNNNSWMFTGRNFYEPEIITTDNTFYSGSCDVNFTYVNNTVYNPLQPELDDFKAELDKFFKNHTSPD 627
                        650       660       670
                 ....*....|....*....|....*....|....*...
gi 82011698 1245 PDL-SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLK 1281
Cdd:cd22370  628 PNLgDLSGINASFVDLQKEMDTLQEVVKQLNESLIDLK 665
CoV_S2 pfam01601
Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic ...
784-1291 0e+00

Coronavirus spike glycoprotein S2; The coronavirus spike glycoprotein forms the characteriztic 'corona' after which the group is named. The Spike glycoprotein is translated as a large polypeptide that is subsequently cleaved to S1 pfam01600 and S2,. The S2 subunit normally contains multiple key components, including one or more fusion peptides (FP), a second proteolytic site (S2') and two conserved heptad repeats (HRs), driving membrane penetration and virus-cell fusion. The HRs can trimerize into a coiled-coil structure built of three HR1-HR2 helical hairpins presenting as a canonical six-helix bundle and drag the virus envelope and the host cell bilayer into close proximity, preparing for fusion to occur.


Pssm-ID: 460263  Cd Length: 502  Bit Score: 726.37  E-value: 0e+00
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    784 YEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQLQVANSLMNGV 863
Cdd:pfam01601    1 GNISIPTNFTISVQTEYIQTTSPKVSVDCAQYVCNGNERCLQLLVQYGSFCSTIEQALQGSARLEDVEVLSMLSISNRAL 80
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    864 TLSTKIKDGINFNvddinFSPVLGCLGSecnrasTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAEIRDLICVQSYNGIK 943
Cdd:pfam01601   81 TLATISNFGSDFN-----FSSFLPCLNS------GRSAIEDLLFDKVVTSGLGTVDAYKKCTKGTSIADLVCAQYYNGIM 149
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    944 VLPPLLSENQISGYTLAATAASLFPPWT-AAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDATN 1022
Cdd:pfam01601  150 VLPGVVDAEKMAMYTASLTGGMAFGGLTgAAAAIPFALAVQARLNYLGLQTDVLQENQKILANAFNNAVGNITDGFTTTA 229
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   1023 SALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSA 1102
Cdd:pfam01601  230 SALSKIQDVVNANAQALNQLTQQLSNNFGAISSSIQDIYSRLDQLEADAQVDRLINGRLAALNAFVTQQLTKASEVKASR 309
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   1103 AQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPKSGYFINVNNS 1182
Cdd:pfam01601  310 QLAQQKVNECVKSQSSRYGFCGNGTHLFSLPQAAPNGIMFLHTVLVPTEYITVKATPGLCVNGTTGYAPRDGQFVLNNTS 389
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   1183 -WMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVAPDLSLDYINVTFLDLQD 1261
Cdd:pfam01601  390 nWYITPRNMYQPRPITGSDFVQISSCDVNFVNITNTKLPPLIPDYVDFNKELEDIYKNLNSTLPDLDLDIFNATILNLTD 469
                          490       500       510
                   ....*....|....*....|....*....|...
gi 82011698   1262 EMN---RLQEAIKVLNQSYINLKDIGTYEYYVK 1291
Cdd:pfam01601  470 EIKdleRLQELIDNLNQTLVDLEWLNRYETYIK 502
HEV_Spike_S1_RBD cd21508
receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine ...
311-608 0e+00

receptor-binding domain of the S1 subunit of the Spike (S) protein from porcine hemagglutinating encephalomyelitis virus; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from porcine hemagglutinating encephalomyelitis virus (HEV), which is associated with acute outbreaks of wasting and encephalitis in nursing piglets from pig farms. Porcine HEV is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. The protein receptor for porcine HEV has not yet been identified. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394835  Cd Length: 298  Bit Score: 636.01  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21508    1 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYS 470
Cdd:cd21508   81 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYS 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  471 QQCFNTPNTYCPCRTSQCIGGAGTGTCPVGTTVRKCFAAVTKATKCTCWCQPDPSTYKGVNAWTCPQSKVSIQPGQHCPG 550
Cdd:cd21508  161 QQCFNTPNTYCPCRTSQCIGGAGTGTCPVGTTVRKCFAAVTNATKCTCWCQPDPSTYKGVNAWTCPQSKVSIQPGQHCPG 240
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|....*...
gi 82011698  551 LGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 608
Cdd:cd21508  241 LGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 298
bat-HKU9-CoV-like_Spike_SD1-2_S1-S2_S2 cd22381
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
622-1311 0e+00

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Rousettus bat coronavirus HKU9 and related betacoronaviruses in the D lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the nobecovirus subgenus (D lineage), including Rousettus bat coronavirus HKU9 (Ro-BatCoV HKU9). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411968 [Multi-domain]  Cd Length: 731  Bit Score: 596.74  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  622 LYGITGQGILIEVNATYYNSwQNLLYDSSGNLYGFRdyLSNRTFLIRSCYSGRVSAVFHANSsEPALMFRNLKCSHVFNN 701
Cdd:cd22381    1 LYGYTGTGVLSTSNLTIPDS-KVFSASSTGDIIAVS--VNGTVYSISPCVSVPISVGYDPGF-ERALLFNGLSCSERARA 76
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  702 ---------TILRQIQLVNYFDSYLGCVVNAYNNTASAVSTCDLTVGSGYCVDYVTALRSRRSFTTGYRFTNFEPFAANL 772
Cdd:cd22381   77 vsepasdywRASVSDGANNTFDTPSGCVYNVINRTTITVNQCSMPLGNSLCLVNNTTAVSARGSLSLLSLVTYDPLYDSS 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  773 VNdSIEPVgglYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQ 852
Cdd:cd22381  157 VT-PLTPV---YWVSIPTNFTLAATTEYIQTTAPKINIDCAKYLCGDSSRCLTVLLQYGTFCDDVNKALARVSTILDASL 232
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  853 LQVANSLMNGVTLSTkikdgiNFNVD-DINFSPVLGCLGSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTG---GA 928
Cdd:cd22381  233 VSLVSELTSDVVRSE------NLAFDgDYNFTGLMGCLGSNCNSKSYRSALSDLLYNKVKVADPGFMQSYQKCIDsqwGG 306
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  929 EIRDLICVQSYNGIKVLPPLLSENQISGYT---LAATAASLFPPWTAAAGV-PFYLNVQYRINGLGVTMDVLSQNQKLIA 1004
Cdd:cd22381  307 NIRDLICTQTFNGISVLPPIVSPGMQALYTsllVGAVASSGYTFGITSVGViPFATQLQFRLNGLGVTTQVLVENQKLIA 386
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1005 SAFNNALDAIQEGFDATNSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTAL 1084
Cdd:cd22381  387 NSFNKALVSIQKGFDATNQALSKMQTVINQHAQQLQTLVQQLGNSFGAISSSINEIFSRLDGLEANAEVDRLINGRMVVL 466
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1085 NAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIA 1164
Cdd:cd22381  467 NTYVTQLLIQASEVRAQAALAKQKISECVKAQSLRNDFCGNGTHVLSIPQLAPNGVLFIHYSYQPTAYALVQTAAGLCFN 546
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1165 GdIGISPKSGYFINVNNS--WMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSS 1242
Cdd:cd22381  547 G-TGYAPRGGLFVLPNNSnlWHFTKMNFYNPVNISYSNTQVLTSCSVNYTTVNYTVLNPSEPSDFNFQEEFDKWYKNQSS 625
                        650       660       670       680       690       700       710
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 82011698 1243 VAPD-LSLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDIGTYEYYVKWPWYVWL--LIGLAGVAMLVLL 1311
Cdd:cd22381  626 QFNNtFNPSDFNFSTVDVNEQLATLTDVVKQLNESFIDLKKLNVYEQTIKWPWYVWLamIAGLVGLALAVVM 697
MHV-like_Spike_S1_NTD cd21625
N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and ...
16-298 0e+00

N-terminal domain of the S1 subunit of the Spike (S) protein from murine hepatitis virus and related betacoronaviruses in the A lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the embecovirus subgenera (A lineage), including murine hepatitis virus (MHV), human coronavirus (HCoV) HKU1 and OC43, and bovine CoV (BCoV). MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract, while HCoV-HKU1 causes mild yet prevalent respiratory disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While most CoVs, including SARS-CoV and MERS-CoV use the C-domain to bind their receptors, several CoVs in the A lineage use the NTD to bind their receptors. MHV binds its protein receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a), through its S1 NTD. BCoV and HCoV-OC43 recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394951  Cd Length: 284  Bit Score: 577.42  E-value: 0e+00
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   16 IGDLKCTTSLINDVDTGVPSISSEVVDVTNGLGTFYVLDRVYLNTTLLLNGYYPISGATFRNMALKGTRLLSTLWFKPPF 95
Cdd:cd21625    1 IGDFKCTTVSINDVNTGAPSISTETVDVSNGLGTYYVLDRVYLNTTLLLNGYYPTSGSTYRNLALKGTLLLSTLWFKPPF 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   96 LSPFNDGIFAKVKNSRFSKDGVIYSEFPAITIGSTFVNTSYSIVVEPHTSLINGNLQGLLQISVCQYTMCEYPHTICHPN 175
Cdd:cd21625   81 LSEFNNGIFAKVKNTKVSKNGVMYSEFPTIVIGSTFVNTSYTVVVQPHTGNSDNKLQGILEISVCQYTMCEYPNTICKPN 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  176 LGNQRIELWHYDTDVVSCLYRRNFTYDVNADYLYFHFYQEGGTFYAYFTDTGFVTKFLFKLYLGTVLSHYYVMPLTCNS- 254
Cdd:cd21625  161 LGNQRIELWHTDTGVPSCLYKRNFTYDVNADWLYFHFYQEGGTFYAYYADTGSVTTFLFSVYLGTVLSHYYVMPLTCNSt 240
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....
gi 82011698  255 ALSLEYWVTPLTTRQFLLAFDQDGVLYHAVDCASDFMSEIMCKT 298
Cdd:cd21625  241 ALTLEYWVTPLTKRQYLLAFNQDGVITNAVDCASDFMSEIKCKT 284
MERS-CoV-like_Spike_SD1-2_S1-S2_S2 cd22379
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
622-1291 1.98e-178

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Middle East respiratory syndrome coronavirus and related betacoronaviruses in the C lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the merbecovirus subgenus (C lineage), including Middle East respiratory syndrome coronavirus (MERS-CoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411966 [Multi-domain]  Cd Length: 682  Bit Score: 544.77  E-value: 1.98e-178
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  622 LYGITGQGILIEVNATYYNSwQNLLYDSSGNLYGFrdYLSNRTFL-IRSCYSGRVSAVFHANSSEPALMFRNLKCSHV-- 698
Cdd:cd22379    1 LYGVTGRGVFQNCTAVGIRQ-QRFVYDSFDNLVGY--HSDDGNYYcVRPCVSVPVSVIYDKSTNTHATLFGSVACEHIst 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  699 -------FNNTILRQIQLVNYFDSYLGCVVNaYNNTASAVSTCDLTVGSGYC-VDYVTALRSRRSFTTGYRFT-NFE-PF 768
Cdd:cd22379   78 mmsqfsrSTQSMLRRRSTNGPLQTAVGCVIG-LVNTSLTVEDCKLPLGQSLCaVPPTLTPRSVSSVPGEQLASiNFNhPL 156
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  769 AANLVNDSiepvggLYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELL 848
Cdd:cd22379  157 QVDQLNSS------GFKVSIPTNFSFGVTQEYIQTTIQKVTVDCKQYVCNGFEKCEQLLREYGQFCSKINQALHGANLRQ 230
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  849 DTTqlqVANSLMNGVTLSTK-IKDGINfnvDDINFSpVLGCLGSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCT-- 925
Cdd:cd22379  231 DDS---VRNLFASIKTSQSQpLIAGLG---GDFNLT-LLEPPSISTGSRSYRSAIEDLLFDKVTIADPGYMQGYDECMkq 303
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  926 GGAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTA----AAGVPFYLNVQYRINGLGVTMDVLSQNQK 1001
Cdd:cd22379  304 GPPSARDLICAQYVAGYKVLPPLYDVNMEAAYTSSLLGSIAGAGWTAglssFAAIPFAQSIFYRLNGVGITQQVLSENQK 383
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1002 LIASAFNNALDAIQEGFDATNSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRL 1081
Cdd:cd22379  384 LIANKFNQALGAMQTGFTTTNLAFQKVQDAVNANAQALSKLASELSNTFGAISSSIGDILKRLDVLEQEAQIDRLINGRL 463
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1082 TALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGL 1161
Cdd:cd22379  464 TSLNAFVAQQLVRSETAARSAQLAKDKVNECVKSQSKRNGFCGQGTHIVSFVINAPNGLYFFHVGYVPTNHVNVTAAYGL 543
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1162 CIAGDIG--ISPKSGYFI-----NVNNSWMFTGSSYYYPEPITQNNV--VVMSTCAVNYT-KAPDLMLNTSTPNlpDFKE 1231
Cdd:cd22379  544 CDSANPTncIAPVNGYFIknnttRIVDEWSYTGSSFYAPEPITSANTryVSPDVTFQNLSnNLPPPLLSNSTDI--DFKD 621
                        650       660       670       680       690       700
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 82011698 1232 ELYQWFKNQSSVAPDL-SLDYINVTFLDLQDEMNRLQEAIKVLNQSYINLKDIGTYEYYVK 1291
Cdd:cd22379  622 ELEEFFKNVSSQIPNFgSISQINTTLLDLSDEMLSLQQVVKALNESYIDLKELGNYTYYQK 682
CoV_Spike_S1-S2_S2 cd21698
S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model ...
785-1282 9.44e-163

S1/S2 cleavage region and the S2 fusion subunit of coronavirus spike (S) proteins; This model represents the S1/S2 cleavage region and the S2 subunit of the spike (S) glycoprotein from coronavirus (CoVs), including three highly pathogenic human CoVs, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect S1 and S2. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV, and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related CoVs. The S1/S2 cleavage region and the S2 fusion subunit play an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411955 [Multi-domain]  Cd Length: 523  Bit Score: 497.71  E-value: 9.44e-163
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  785 EIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDttqlqvaNSLMNGVT 864
Cdd:cd21698   32 NIAIPSNFTLSVTTEYLQVTMTKVSVDCTTYVCGGSPRCKNLLLQYGSACDTIEQALRGIAVLED-------SEVSNMFS 104
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  865 LST-KIKDGINFNVDDINFSPVLgclgSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAEIRDLICVQSYNGIK 943
Cdd:cd21698  105 TSKqALKLAIIKSFGGFNFSQIL----PTPSRPSGRSAIEDLLFTKVVTAGLGTVDQYKNCTKGIAIADLACAQYYNGIM 180
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  944 VLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDATNS 1023
Cdd:cd21698  181 VLPPVADAEKMAMYTGSLTAGMVFGGITAAAAIPFSLAMQARLNYVGLQQNVLLENQKLLANSFNKAIGNISDAFSSTSS 260
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1024 ALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAA 1103
Cdd:cd21698  261 ALQKIQDVVNQQAQALNTLTSQLSNNFGAISSSIQDIYQRLDKLEADVQVDRLITGRLAALNAFVTQQLIKAAEVRQSRR 340
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1104 QAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPK-SGYFINVNNS 1182
Cdd:cd21698  341 LAQQKINECVKSQSSRYGFCGNGTHLFSIPQSAPSGIVFLHTVLVPTSYKNVTAYPGICVDGKAGSPLEgPLVFIQNNNH 420
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1183 WMFTGSSYYYPEPITQNNVVVMSTCAVNYTkapdlMLNTS------TPNLPDFKEELYQWFKNQSS-VAPDLSLDYINVT 1255
Cdd:cd21698  421 WFVTPRNMYEPRIITTADFVQITSCDANVT-----IVNNTvnldpvIPDYVDVNEELDDYIQNLPNhTLPDLDLSGYNAT 495
                        490       500
                 ....*....|....*....|....*..
gi 82011698 1256 FLDLQDEMNRLQEAIKVLNQSYINLKD 1282
Cdd:cd21698  496 ILNISSEIDRLNEVAKNLNQSVVELQE 522
HCoV-OC43-like_Spike_S1_RBD cd21485
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus OC43 ...
311-607 3.90e-151

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus OC43 and related proteins; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from several betacoronaviruses including human coronavirus OC43 (HCoV-OC43) and bovine respiratory coronavirus (BCoV), among others. HCoV-OC43 is of zoonotic origin and is endemic in the human population, causing mild respiratory tract infections and possible severe complications or fatalities in young children, the elderly, and immunocompromised individuals. These viruses are related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. It has been reported that HCoV-OC43 uses 9-O-acetyl-sialic acid (9-O-Ac-Sia) as a receptor, which is terminally linked to oligosaccharides decorating glycoproteins and gangliosides at the host cell surface. HCoV-OC43 appears to bind 9-O-Ac-Sia at the NTD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394832  Cd Length: 312  Bit Score: 459.09  E-value: 3.90e-151
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21485    1 NGYTVQPIADVYRRIPNLPDCNIEAWLNDKSVPSPLNWERKTFSNCNFNMSSLMSFIQADSFTCNNIDAAKIYGMCFSSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSF------GSRGL 464
Cdd:cd21485   81 TIDKFAIPNGRKVDLQLGNLGYLQSFNYRIDTTATSCQLYYNLPAANVSVSRFNPSTWNRRFGFTEQSVfkpqpaGVFTD 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  465 HDAVYSQQCFNTPNTYCPCRT--SQCIGGA----------GTGTCPVGTTVRKCFAAVTkatkCTCWCQPDPSTYKGVNA 532
Cdd:cd21485  161 HDVVYAQHCFKAPTNFCPCKLdgSLCVGSGpgidagyknnGIGTCPAGTNYLTCHNLCQ----CDCLCTPDPITSKATGP 236
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 82011698  533 WTCPQSKVSIQPGQHCPGLGLVEDDCSGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQ 607
Cdd:cd21485  237 YKCPQTKYLVGIGEHCSGLAIKSDYCGGNPCTCQPQAFLGWSVDSCLQGDRCNIFANFILHDVNSGTTCSTDLQK 311
gammaCoV_Spike_SD1-2_S1-S2_S2 cd22372
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1280 1.03e-148

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from avian infectious bronchitis coronavirus (IBV) and related gammacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from gammacoronaviruses, including avian infectious bronchitis virus, and Beluga whale coronavirus SW1 (whale-CoV SW1). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411959 [Multi-domain]  Cd Length: 661  Bit Score: 466.00  E-value: 1.03e-148
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  611 IITTDVCVNYDLYGITGQGILIEV--NATYYNSWQN---LLYDSSGNLygfrdylsnrtflirscysgrvsAVFHANSSE 685
Cdd:cd22372    3 NITLNKCVDYNIYGRVGQGFITNVtdSAADYNYLADgglAILDTSGAI-----------------------DIFVVQGEY 59
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  686 PALMFRNLKCSHVFNNTILRQIQLVNYFDSYlgcvvnayNNTASAvstcdlTVGSGYCVDYVTALRSRRSFTTG------ 759
Cdd:cd22372   60 GLNYYKVNPCEDVNQQFVVSGGNLVGILTSR--------NETGSQ------LLENQFYIKLTNGTRRRRRSISEnvtscp 125
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  760 ---YRFTNFEPFAAN------LVNDSIEPVGGLYE-IQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAE 829
Cdd:cd22372  126 yvsYGKFCIKPDGSIstivpqELETFVAPLLNVTEnVLIPNSFNLTVTDEYIQTRMDKVQINCLQYVCGNSLECRKLFQQ 205
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  830 YGSFCENINAILTEVNELLDTTQLQVANSLMNGVTLSTKIKdgiNFNVDDINFSPVLgclgSECNRASTRSAIEDLLFDK 909
Cdd:cd22372  206 YGPVCDNILSIVNSVNQKEDMELLSFYSSTKPGGFNTPVFN---NVSTGGFNISLLL----PPPSSPQGRSFIEDLLFTK 278
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  910 VKLSDVGFVQAYNNCTGG--AEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRIN 987
Cdd:cd22372  279 VETVGLPTDDAYKKCTAGplGFLKDLVCAQEYNGLLVLPPIITAEMQTMYTGSLVASMAFGGITAAGAIPFATQIQARIN 358
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  988 GLGVTMDVLSQNQKLIASAFNNALDAIQEGFDATNSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDAL 1067
Cdd:cd22372  359 HLGITQSLLLKNQEKIAASFNKAIGHMQEGFRSTSLALQQIQDVVNKQSAILTETMASLNKNFGAISSVIQDIYQQLDAI 438
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1068 EAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSY 1147
Cdd:cd22372  439 QADAQVDRLITGRLSSLSVLASAKQAEYYKVSQQRELATQKINECVKSQSNRYGFCGNGRHVLTIPQNAPNGIVFIHFTY 518
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1148 VPTKYVTAKVSPGLCI----AGDIGISPK--SGYFINVNNSWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNT 1221
Cdd:cd22372  519 TPESFVNVTAIVGFCVnpanGSQYAIVPAngRGIFIQVNGTYYITARDMYMPRDITAGDIVTLTSCQANYVSVNKTVITT 598
                        650       660       670       680       690       700
                 ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 82011698 1222 ST-PNLPDFKEELYQWFKNQSSVAPDlsLDYINVT--FLDLQDEMNRLQEAIKVLNQSYINL 1280
Cdd:cd22372  599 FVdNDDFDFDDELSKWWNETKHELPD--FDQFNYTipILNISNEIDRIQEVIQGLNDSLIDL 658
SARS-CoV-like_Spike_SD1-2_S1-S2_S2 cd22378
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
624-1287 2.99e-140

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from SARS-CoV-2 (COVID-19) and related betacoronaviruses in the B lineage; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from betacoronaviruses in the sarbecovirus subgenus (B lineage), including highly pathogenic human CoVs such as Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS-CoV-2 (also known as a 2019 novel coronavirus or 2019-nCoV). The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. Notably, SARS-CoV-2 has a functional polybasic (furin) cleavage site through the insertion of PRRAR*SV (* indicates the cleavage site) at the S1/S2 interface, which is absent in SARS-CoV and other SARS-related coronaviruses. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411965 [Multi-domain]  Cd Length: 662  Bit Score: 443.67  E-value: 2.99e-140
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  624 GITGQGILIEVNATYyNSWQNLLYDSSGNLYGFRDYLSNRTFLIRSCYSGRVSAVFHAN--SSEPALMFRNLKCSHVfnN 701
Cdd:cd22378    3 GLTGTGVLTPSSKRF-QPFQQFGRDVSDFTDSVRDPKTLEILDISPCSFGGVSVITPGTnaSSEVAVLYQDVNCTDV--P 79
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  702 TILRQIQLV----------NYFDSYLGCVVNAYNNTASavSTCDLTVGSGYCVDYVTALRSR---RSFTTGYRFTNFEPF 768
Cdd:cd22378   80 TAIHADQLTpawrvystgsNVFQTQAGCLIGAEHVNTS--YECDIPIGAGICASYHTVSLLRstsQKSIVAYTMSLGAEN 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  769 AANLVNDSIepvgglyeiQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELL 848
Cdd:cd22378  158 SIAYSNNSI---------AIPTNFSISVTTEVMPVSMAKTSVDCTMYICGDSTECSNLLLQYGSFCTQLNRALSGIAVEQ 228
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  849 DTTQLQVAnSLMNGVTLSTKIKDGINFNvddinFSPVLgclgSECNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGA 928
Cdd:cd22378  229 DKNTQEVF-AQVKQMYKTPTIKDFGGFN-----FSQIL----PDPSKPTKRSFIEDLLFNKVTLADAGFMKQYGDCLGDI 298
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  929 EIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAG----VPFYLNVQYRINGLGVTMDVLSQNQKLIA 1004
Cdd:cd22378  299 NARDLICAQKFNGLTVLPPLLTDEMIAAYTAALVSGTATAGWTFGAGaalqIPFAMQMAYRFNGIGVTQNVLYENQKQIA 378
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1005 SAFNNALDAIQEGFDATNSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTAL 1084
Cdd:cd22378  379 NQFNKAISQIQESLTTTSTALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSL 458
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1085 NAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIA 1164
Cdd:cd22378  459 QTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLMSFPQAAPHGVVFLHVTYVPSQERNFTTAPAICHE 538
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1165 GDIGIsPKSGYFINVNNSWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSva 1244
Cdd:cd22378  539 GKAYF-PREGVFVSNGTSWFITQRNFYSPQIITTDNTFVSGNCDVVIGIINNTVYDPLQPELDSFKEELDKYFKNHTS-- 615
                        650       660       670       680
                 ....*....|....*....|....*....|....*....|....*.
gi 82011698 1245 PDLSLD---YINVTFLDLQDEMNRLQEAIKVLNQSYINLKDIGTYE 1287
Cdd:cd22378  616 PDVDLGdisGINASVVNIQKEIDRLNEVAKNLNESLIDLQELGKYE 661
HKU1-like_CoV_Spike_S1_RBD cd21478
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1 ...
311-608 1.66e-130

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1 and related coronaviruses; This family contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, human coronavirus OC43 (HCoV-OC43), mouse hepatitis virus (MHV), porcine hemagglutinating encephalomyelitis virus (HEV), and other related coronaviruses. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease. HCoV-OC43 is of zoonotic origin and is endemic in the human population, causing mild respiratory tract infections and possible severe complications or fatalities in young children, the elderly, and immunocompromised individuals. MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract. Porcine HEV is associated with acute outbreaks of wasting and encephalitis in nursing piglets from pig farms. These viruses are related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBDs of MHV and HCoV-OC43 are located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394825  Cd Length: 223  Bit Score: 400.68  E-value: 1.66e-130
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21478    1 TGYTVQPIADVYRRIPNLPDCDIEEWLNAPTVPSPLNWERKTFSNCNFNMSSLLSLVQADSFSCNNIDASKIYGMCFGSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSF---GSRGLHDA 467
Cdd:cd21478   81 TIDKFAIPNSRKVDLQLGSSGYLQSFNYRIDTAATSCQLYYSLPANNVTVTNFNPSSWNRRYGFNEFKPkpaGNLGNHDV 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  468 VYSQQCFNTPNTYCPCRtsqciggagtgtcpvgttvrkcfaavtkatkctcwcqpdpstykgvnawtcpqskvsiqpgqh 547
Cdd:cd21478  161 VYSQQCFNVPNTYCPCK--------------------------------------------------------------- 177
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 82011698  548 cpglglveddcsgnpCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQG 608
Cdd:cd21478  178 ---------------CSCYPNAFLGWSADSCLSNGRCNIFANFILNGVNSGTTCSTDLQKP 223
alphaCoV_Spike_SD1-2_S1-S2_S2 cd22369
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
611-1281 4.98e-129

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) protein from alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses including human coronaviruses (HCoVs), HCoV-NL63, and HCoV-229E, and porcine coronaviruses, transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV), among others. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP), and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1 the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411956 [Multi-domain]  Cd Length: 666  Bit Score: 413.61  E-value: 4.98e-129
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  611 IITTDVCVNYDLYGITGQGILIEVNATYYNSwqnLLY-DSSGNLYGFRDYLSNRTFLIRSC--------YSGRVSAVFHA 681
Cdd:cd22369    4 VVHLNVCTDYTIYGITGRGIIRKSNSTYIAG---LYYtSNSGQLLGFKNSTTGEVFSVTPCqlssqvavVSDNIVGVMSA 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  682 NSSEpalmfrnlkcSHVFNNTilrqIQLVNYFDSYlgcvvNAYNNTASAVstcdLTVGS-GYCVD-YVTALRSRRSFTTG 759
Cdd:cd22369   81 TNNV----------SLGFNNT----IETPSFYYHS-----NGAENCTEPV----LTYGSiGVCADgSITEVTPRSVSPEP 137
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  760 yrftnfepfaanlvndsIEPVGGLYeIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENI-- 837
Cdd:cd22369  138 -----------------VSPIITGN-ISIPSNFTVSVQVEYLQMYLKPVSVDCSTYVCNGNPRCLQLLTQYASACRTIee 199
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  838 ----NAIL--TEVNELL--DTTQLQVANslmngvtlstkikdgINFNVDDINFSPVLGclgsecNRASTRSAIEDLLFDK 909
Cdd:cd22369  200 alqlSARLesVEVNSMItvSEEALRLAN---------------ISTFFDDYNLSAVLP------AGVGGRSAIEDLLFDK 258
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  910 VKLSDVGFVQA-YNNCTG--GAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRI 986
Cdd:cd22369  259 VVTSGLGTVDEdYKACTKglGIAAADVACAQYYNGIMVLPGVVDAEKMALYTASLTGGMVLGGFTAAAAIPFSLAVQSRL 338
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  987 NGLGVTMDVLSQNQKLIASAFNNAL-----------DAIQEGFDATN---SALVKIQAVVNANAEALNNLLQQLSNRFGA 1052
Cdd:cd22369  339 NYVALQTDVLQRNQQILANSFNSAMgnitvafsevnDAIQQTSDAINtvaQALNKVQNVVNEQGQALSQLTKQLASNFQA 418
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1053 ISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISL 1132
Cdd:cd22369  419 ISSSIEDIYNRLDGLAADAQVDRLITGRLAALNAFVTQTLTKYTEVRASRQLAQQKINECVKSQSSRYGFCGNGTHLFSI 498
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1133 VQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGI--SPKSGYFINVNNSWMFTGSSYYYPEPITQNNVVVMSTCAVN 1210
Cdd:cd22369  499 VNAAPDGIMFLHTVLLPTEYVTVAAWAGLCVDGKAYVlrDDVVLTLFKLNDKYYVTPRDMFEPRVPVSSDFVQISNCNVT 578
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1211 YTKAPDLMLNTSTPNLPDFKEELYQWFKN-QSSVAPDLSLDYINVTFLDLQDEMN--------------RLQEAIKVLNQ 1275
Cdd:cd22369  579 YVNITSDELPEVIPDYIDVNKTLEEFLANlPNYTLPDLPLDIFNATYLNLTGEIAdlenksesllnttvELQELIDNINN 658

                 ....*.
gi 82011698 1276 SYINLK 1281
Cdd:cd22369  659 TLVDLE 664
MHV-like_Spike_S1_RBD cd21484
receptor-binding domain of the S1 subunit of the Spike (S) protein from mouse hepatitis virus ...
312-606 1.51e-126

receptor-binding domain of the S1 subunit of the Spike (S) protein from mouse hepatitis virus and other rodent coronaviruses; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from mouse hepatitis virus (MHV) and other rodent coronaviruses. MHV is the most common viral pathogen in contemporary laboratory mouse colonies manifesting as a primary infection in the upper respiratory tract. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). MHV uses mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a) as the receptor; the RBD of MHV is located at the NTD. Most CoVs, such as SARS-CoV and MERS-CoV, use the C-domain to bind their receptors. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394831  Cd Length: 264  Bit Score: 391.94  E-value: 1.51e-126
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  312 GYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSIT 391
Cdd:cd21484    2 GYTVQPVGVVYRRVPNLPDCKIEEWLTAKSVPSPLNWERKTFQNCNFNLSSLLRYVQAESLSCNNIDASKVYGMCFGSIS 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  392 IDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSRGLHDAVYSQ 471
Cdd:cd21484   82 IDKFAIPNSRRVDLQLGNSGFLQSFNYKIDTRATSCQLYYSLAQNNVTVNNHNPSSWNRRYGFNDVATFGKGKHDVAYAQ 161
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  472 QCFNTPNTYCPCRTSQCIGgagtgTCPVGTTVRkcfaavtkatkctcwcqpdpstykgvnawtCPQSKVSIQPGQHCPGL 551
Cdd:cd21484  162 QCFTVGASYCPCAQPSIVS-----PCTTDKPKR------------------------------CLQGDSCLGVGDHCDGL 206
                        250       260       270       280       290
                 ....*....|....*....|....*....|....*....|....*....|....*.
gi 82011698  552 GLVEDDCSG-NPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQ 606
Cdd:cd21484  207 GVLEDKCGGsNGCNCAADAFVGWSHDSCLSNGRCQIFANLLLNGINSGTTCSTDLQ 262
alphaCoV-HKU2-like_Spike_SD1-2_S1-S2_S2 cd22371
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV ...
624-1332 2.71e-122

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the CoV spike (S) glycoprotein from Rhinolophus bat coronavirus HKU2 and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Wencheng shrew coronavirus (WESV), Lucheng Rn rat coronavirus (LRNV), and two bat viruses (Rhinolophus bat coronavirus HKU2 and BtRf-AlphaCoV/YN2012). Members of this group form a distinct cluster that is separated from the other alphacoronaviruses. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411958 [Multi-domain]  Cd Length: 686  Bit Score: 396.08  E-value: 2.71e-122
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  624 GITGQGILIEVNATYyNSWQNLLYDSSGNLYgFRdyLSNRTFLIRSCYSGRVSaVFHANSSEPALMFRNLKCSHVFNNTI 703
Cdd:cd22371    3 GVTFQGILYETNFTF-DSFYNLLYKGSMVKY-VR--ILGVVYEVEPCNEFSYS-VLKNNSSSYGTLYSGADCNQIDTKTF 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  704 LRQIQLVNYFDSYLGCVVNAYNNTASAVsTCDLTVGSGYCVDY-VTALRSRRSFTTGYRftnfepfaanlvNDSIEPVGG 782
Cdd:cd22371   78 RFKARSHTGTNTSLGCLFNASYTNDTYT-TCLNPLGNGFCADVnVTSPVVGNIGIQKHD------------TDYVRPILT 144
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  783 LYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEVNELLDTTQLqvanSLMNG 862
Cdd:cd22371  145 EQFIELPLDHQLVVKEQFLQTSMPKFDVDCERYICDVSKACRELLFKYGGFCSKITADIKGSSILLDSQIL----GLYKT 220
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  863 VTLSTKIkdgINFNVDDINFSPVLgclgsecNRASTRSAIEDLLFDKVKLSDVGFVQAYNNCTGGAeIRDLICVQSYNGI 942
Cdd:cd22371  221 IAVDFSS---PDVDFGDFNFSMFM-------SEKNGRSFIEDLLFDKIVTTGPGFYQDYYDCKKMN-LQDLTCAQYYNGI 289
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  943 KVLPPLLSENQISGYTLAATAASLFPPWTAAAG-VPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDAT 1021
Cdd:cd22371  290 MVIPPIMDDETIGMYGGIVAASMTAGLFGGQAGmVTWNTAMAGRLNALGVTQDALVEDVNKLANGFNNLTQSVSKLAKTT 369
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1022 NSALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQ-QLSDSTLvKF 1100
Cdd:cd22371  370 SQALSAIQAVVNQNAAQVEQLVQGLSENFGAISNNFEVIAERLEKLEADQQMDRLINGRMNVLQNFVTNyKLKISEL-KS 448
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1101 SAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISP---KSGYFI 1177
Cdd:cd22371  449 TQRLVQSLINECVYAQSLRNGFCGDGLHVMSLMQNAPDGIMFFHYTLKPNNTIIVKTTPGLCLSNEVCIKPidaKFGVLV 528
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1178 NVNNS-WMFTGSSYYYPEPITQNNVVVMStCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKNQSSVAPDLSLDYINVTF 1256
Cdd:cd22371  529 SANDSyWHFTPRNIYNPENITNSNIIAVS-GGANYTTVNNTIDIIEPPQNPPIDEEFRELYKNVTLELEQLKNITFDMSK 607
                        650       660       670       680       690       700       710
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 82011698 1257 LDLQDEMNRLQEAIKVLNQSYINLKDIGTYEYYVKWPWYVWLLIGLAGVAMLVLLFFICCCTGcgtscfkkCGGCC 1332
Cdd:cd22371  608 LNLTYEIDRLNEIAENVSKLHVTVSEFNKYVQYVKWPWYVWLAIFLVLILFSFLMLWCCCATG--------CCGCC 675
delta-PDCoV-like_Spike_SD1-2_S1-S2_S2 cd22373
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
615-1279 1.24e-118

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine coronavirus HKU15, avian coronaviruses, and related deltacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine coronavirus PDCoV, and several avian coronaviruses such as quail deltacoronavirus (QdCoV) UAE-HKU30, white-eye coronavirus HKU16, common moorhen coronavirus HKU21, thrush CoV HKU12, and munia CoV HKU13, all from the Buldecovirus subgenus of deltacoronaviruses. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411960 [Multi-domain]  Cd Length: 648  Bit Score: 384.96  E-value: 1.24e-118
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  615 DVCVNYDLYGITGQGILIEVNATYYNSwqnLLYDSS-GNLYGFRDYLSNRTFLIRSCYSGRVSAVFhanssepalmfrnl 693
Cdd:cd22373    1 DVCTDYTIYGVSGTGIIKPSDLQLHNG---IAFTSPtGELYAFKNITTGKTYQVLPCETPSQLIVI-------------- 63
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  694 kcshvfNNTILRQIQLVNY----FDSYLGCVVNAY--NNTASAVSTCDLTVGS-GYCVDYVTAlrsrrsfttgyrftnfe 766
Cdd:cd22373   64 ------NNTIVGAITSSNStengFTTTIVTPTFYYstNATSFNCTKPVLSYGPiSVCSDGAIV----------------- 120
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  767 pfAANLVNDSIEPVGGLY--EIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAILTEV 844
Cdd:cd22373  121 --GTSTLQDTRPSIVSLYdgEVEIPSAFTLSVQTEYLQVQAEQVVVDCPQYVCNGNSRCLQLLAQYTSACSNIESALHSS 198
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  845 NELLDTTQLQVANSLMNGVTLStKIKdgiNFNvDDINFSPVLGclgsecNRASTRSAIEDLLFDKVKLSDVGFV-QAYNN 923
Cdd:cd22373  199 AQLDSREITNMFQTSTQSLELA-NIT---NFK-GDYNFTSILT------TKIGGRSAIEDLLFNKVVTNGLGTVdQDYKS 267
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  924 CTGGAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRINGLGVTMDVLSQNQKLI 1003
Cdd:cd22373  268 CSKDMAIADLVCSQYYNGIMVLPGVVDAEKMAMYTGSLTGAMVFGGLTAAAAIPFSTAVQARLNYVALQTNVLQENQKIL 347
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1004 ASAFNNAL-----------DAIQEGFDATNS---ALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSRLDALEA 1069
Cdd:cd22373  348 AESFNQAVgnislalssvnDAIQQTSEALNTvanAINKIQTVVNQQGEALSHLTAQLSNNFQAISTSIQDIYNRLDEVEA 427
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1070 KAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFIHFSYVP 1149
Cdd:cd22373  428 NQQVDRLITGRLAALNAYVTQLLNQMSQIRQSRLLAQQKINECVKSQSSRYGFCGNGTHLFSITQAAPNGIFFMHAVLVP 507
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1150 TKYVTAKVSPGLCIAGDIGIS--PKSGYFiNVNNSWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLNTSTPNLP 1227
Cdd:cd22373  508 TKFTRVNASAGICVDNTKGYSlqPQLILY-QFNNSWRVTPRNMYEPRLPRQADFIPLTDCSVTFYNTTAADLPNIIPDYV 586
                        650       660       670       680       690
                 ....*....|....*....|....*....|....*....|....*....|....*....
gi 82011698 1228 DFKEELYQWFKNQSSVA-PDLSLDYINVTFLDLQDEMNRLQEAIKVLN------QSYIN 1279
Cdd:cd22373  587 DVNQTVSDIIDNLPTPTpPQLDVDIYNNTILNLTQEINDLQERSKNLSqiadrlQQYID 645
delta-PiCoV-like_Spike_SD1-2_S1-S2_S2 cd22374
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
599-1331 6.38e-116

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Pigeon coronavirus UAE-HKU29, and related avian deltacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Pigeon coronavirus UAE-HKU29, and related avian deltacoronaviruses including Falcon coronavirus UAE-HKU27, Magpie-robin coronavirus HKU18, Sparrow coronavirus HKU17, and Night heron coronavirus HKU19. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the (C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HCoV-KU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Ro-BatCoV HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411961 [Multi-domain]  Cd Length: 739  Bit Score: 380.39  E-value: 6.38e-116
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  599 TTCSTDLqqgnTIITTDVCVNYDLYGITGQGILIEVNATYYnswQNLLYDS-SGNLYGFRDYLSNRTFLIRSC------- 670
Cdd:cd22374   14 STGTTDI----STVYLDVCTKYNIYGKTGTGIIRLTNQSYI---AGLYYTSpSGDLLAFKNVTTQTVYSVTPCrlssqva 86
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  671 -YSGRVSAVFhanSSEPALMFRNLKcshvfnntilRQIQLVNYFDSYLGcvvnayNNTASAVStcdLTVGS-GYCVDyvt 748
Cdd:cd22374   87 vYNGSIIAAF---TSTENFTIADFT----------YSRATPMFYYHSIG------NDTCETPV---ITFGSiGVCPG--- 141
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  749 alrsrrsftTGYRFTNFEPFAAnlvnDSIEPVGGLyEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLA 828
Cdd:cd22374  142 ---------GGLHFVDPTSNEF----TNVVPISTQ-NISIPKNFTVSIQTEYIQIEQQPVTVDCRQYVCNGNPRCLQLLM 207
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  829 EYGSFCENINAILTeVNELLDTTQLQvanSLMNGVTLSTKIKDGINFNVDDINFSpvLGCLGSECNRAstRSAIEDLLFD 908
Cdd:cd22374  208 QYTSACSTIEQALS-LNARLEAASIQ---TMLTYSPETLKLANITNFQSDDVNYN--LTNILPKKYQG--RSAIEDLLFD 279
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  909 KVKLSDVGFV-QAYNNCTGGAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRIN 987
Cdd:cd22374  280 KVVTNGLGTVdQDYKACTNGVSIADLVCAQYYNGIMVLPGVADPEKMAQYTASLTGGMVFGGLTSAAAIPFSLAVQSRLN 359
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  988 GLGVTMDVLSQNQKLIASAFNNALDAIQEGFDATN--------------SALVKIQAVVNANAEALNNLLQQLSNRFGAI 1053
Cdd:cd22374  360 YVALQTDVLQQNQQILADSFNNAMGNITLAFKEVSeglsqvsgaittvaNALTKIQTVVNSQGQALATLTEQLANNFQAI 439
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1054 SASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLV 1133
Cdd:cd22374  440 SASIADIYNRLNQLEADAQVDRLITGRLAALNAFVTQTLSKLAEVRQARQLALDKINECVKSQSSRYGFCGNGTHLFSIV 519
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1134 QNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAG-DIGISPKSGYFINVNNSWMFTGSSYYYPEPITQNNVVVMSTCAVNYT 1212
Cdd:cd22374  520 NAAPYGFVFFHTVLLPTQYATVQAYSGICQNGrALALKDPSLALFRGTDKYLVTPRNMYQPRTAAQADFVYIESCTVTYL 599
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1213 KAPDLMLNTSTPNLPDFKEELYQWFKN-QSSVAPDLSLDYINVTFLDLQDEMN--------------RLQEAIKVLNQSY 1277
Cdd:cd22374  600 NLTDTTIDAVIPDYVDVNKTVEDILNNlPNYTKPDLDIGRYNNTILNLTTEINdlngraenlsqiveNLEEYIKKINATL 679
                        730       740       750       760       770
                 ....*....|....*....|....*....|....*....|....*....|....
gi 82011698 1278 INLKDIGTYEYYVKWPWYVWLLIGLAGVAMLVLLFFICCCTGCGTSCFKKCGGC 1331
Cdd:cd22374  680 VDLEWLNRVETYIKWPWWVWLLIALAITAFVCILVTIFLCTGCCGGCFGCCGGC 733
TGEV-like_Spike_SD1-2_S1-S2_S2 cd22377
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
610-1313 9.78e-113

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from transmissible gastroenteritis virus and related alphacoronaviruses; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from porcine transmissible gastroenteritis virus (TGEV), canine coronavirus (CCoV), and feline coronavirus (FCoV). They display greater than 96% sequence identity and have been grouped in the same species, alphacoronavirus 1, within the Alphacoronavirus genus. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411964 [Multi-domain]  Cd Length: 751  Bit Score: 372.17  E-value: 9.78e-113
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  610 TIITTDVCVNYDLYGITGQGILIEVNAT-----YYNSwqnllydSSGNLYGFRDYLSNRTFLIRSC--------YSGRVS 676
Cdd:cd22377    3 SVLVKDECTDYNIYGFQGTGIIRNTTSRlvaglYYTS-------ISGDLLAFKNSTTGEIFTVVPCdltaqaavINDEIV 75
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  677 AVFHANSSEPALMFRNLKCSHVFNNTILrqiQLVNYFDSYLGCVVNAYNNTASAVSTCDLTVGS-GYCVdyvtalrsrrs 755
Cdd:cd22377   76 GAITSVNQTDLFEFVNHTQSRRSRRSTL---GLVHTYTMPQFYYITKWNNDTSTNCTSVITYSSfAICN----------- 141
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  756 fTTGYRFTNFEpfAANLVNDS---IEPVGgLYEIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGS 832
Cdd:cd22377  142 -TGEIKYVNVT--HVEIVDDSigvIKPIS-TGNITIPKNFTVAVQAEYIQIQVKPVVVDCAKYVCNGNRHCLKLLTQYTS 217
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  833 FCENI-NAILT-------EVNELLDTTQ--LQVA------NSLMNGVTLSTKIKDGINfnvddiNFSPvlgclgsecNRA 896
Cdd:cd22377  218 ACQTIeNALNLgarleslMLNDMITVSDrsLELAtvekfnSTVLGGEKLGGFYFDGLK------DLLP---------PRI 282
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  897 STRSAIEDLLFDKVKLSDVGFV-QAYNNCTGGAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAG 975
Cdd:cd22377  283 GKRSAIEDLLFNKVVTSGLGTVdDDYKKCSAGTDVADLVCAQYYNGIMVLPGVVDDNKMAMYTASLIGGMALGSITSAVA 362
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  976 VPFYLNVQYRINGLGVTMDVLSQNQKLIASAFNNAL-----------DAIQ---EGFDATNSALVKIQAVVNANAEALNN 1041
Cdd:cd22377  363 VPFAMQVQARLNYVALQTDVLQENQKILANAFNNAIgnitlalgkvsNAITttsDGFNTMASALTKIQSVVNQQGEALSQ 442
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1042 LLQQLSNRFGAISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRIN 1121
Cdd:cd22377  443 LTSQLQKNFQAISSSIAEIYNRLEKVEADAQVDRLITGRLAALNAYVSQTLTQYAEVKASRQLAMEKVNECVKSQSDRYG 522
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1122 FCGNGNHIISLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIA-GDIGISPKSGYFI-NVNNSWMFTGSSYYYPEPITQN 1199
Cdd:cd22377  523 FCGNGTHLFSLVNSAPDGLLFFHTVLLPTEWEEVTAWSGICVNdTYAYVLKDFLTSIfSYNGTYMVTPRNMFQPRKPQMS 602
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1200 NVVVMSTCAVNYtkapdlmLNTSTPNLPDF-----------KEELYQWFKNQSSVAPDLSLDYINVTFLDLQDEMNR--- 1265
Cdd:cd22377  603 DFVQITSCEVTF-------LNTTYTTFQEIvidyidinktiADMLEQYNPNYTVPELDLQLEIFNQTKLNLTAEIDQleq 675
                        730       740       750       760       770
                 ....*....|....*....|....*....|....*....|....*....|....*....
gi 82011698 1266 -----------LQEAIKVLNQSYINLKDIGTYEYYVKWPWYVWLLIGLAGVAMLVLLFF 1313
Cdd:cd22377  676 radnltniaheLQQYIDNLNKTLVDLEWLNRIETYVKWPWYVWLLIGLVVVFCIPLLLF 734
HKU1_N5-like_CoV_Spike_S1_RBD cd21482
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, ...
311-605 1.34e-110

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, isolate N5 and isolate N2; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, isolates N5 and N2. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs, and most likely, for HKU1.


Pssm-ID: 394829  Cd Length: 304  Bit Score: 350.52  E-value: 1.34e-110
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21482    1 SGFTVKPVATVYRRIPNLPDCDIDNWLNNVSVPSPLNWERRIFSNCNFNLSTLLRLVHVDSFSCNNLDKSKIFGSCFNSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSrglHDAVYS 470
Cdd:cd21482   81 TVDKFAIPNRRRDDLQLGSSGFLQSSNYKIDISSSSCQLYYSLPLLNVTINNFNPSSWNRRYGFGSFNVSS---YDVVYS 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  471 QQCFNTPNTYCPCRTSQCIGGAG-----TGTCPVGTTVRKCFAAVTKATK--CTCWCQPDPSTYKGVNawTCPQSKVSIQ 543
Cdd:cd21482  158 DHCFSVNSDFCPCADPSVVNSCVkskplSAICPAGTKYRHCDLDTTLYVKnwCRCSCLPDPISTYSPN--TCPQKKVVVG 235
                        250       260       270       280       290       300
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 82011698  544 PGQHCPGLGLVEDDC----SGNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDL 605
Cdd:cd21482  236 IGEHCPGLGINEEKCgtqlNHSSCSCSPDAFLGWSFDSCISNNRCNIFSNFIFNGINSGTTCSNDL 301
HKU1_N1_CoV_Spike_S1_RBD cd21483
receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, ...
311-607 5.03e-109

receptor-binding domain of the S1 subunit of the Spike (S) protein from human coronavirus HKU1, isolate N1; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from human coronavirus (CoV) HKU1, isolate N1. HKU1 is a human betacoronavirus that causes mild yet prevalent respiratory disease, and is related to the zoonotic SARS and MERS betacoronaviruses, which have high fatality rates and pandemic potential. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs use the C-domain to bind their receptors. Although a protein receptor has not yet been identified for HKU1, antibodies against the C-domain, but not those against the NTD, blocked HKU1 infection of cells, suggesting that the S1 C-domain is the primary HKU1 receptor-binding site. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs, and most likely, for HKU1.


Pssm-ID: 394830  Cd Length: 306  Bit Score: 346.33  E-value: 5.03e-109
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  311 NGYTVQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSI 390
Cdd:cd21483    1 SGFTVKPVATVHRRIPDLPDCDIDKWLNNFNVPSPLNWERKIFSNCNFNLSTLLRLVHTDSFSCNNFDESKIYGSCFKSI 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  391 TIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHYNPSSWNRRYGFNNQSFGSrglHDAVYS 470
Cdd:cd21483   81 VLDKFAIPNSRRSDLQLGSSGFLQSSNYKIDTTSSSCQLYYSLPAINVTINNYNPSSWNRRYGFNNFNLSS---HSVVYS 157
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  471 QQCFNTPNTYCPCR----TSQCIG-GAGTGTCPVGTTVRKCFAAVT--KATKCTCWCQPDPSTykGVNAWTCPQSKVSIQ 543
Cdd:cd21483  158 RYCFSVNNTFCPCAkpsfASSCKShKPPSASCPIGTNYRSCESTTVldHTDWCRCSCLPDPIT--AYDPRSCSQKKSLVG 235
                        250       260       270       280       290       300       310
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  544 PGQHCPGLGLVEDDCS------GNPCTCKPQAFIGWSSETCLQNGRCNIFANFILNDVNSGTTCSTDLQQ 607
Cdd:cd21483  236 VGEHCAGFGVDEEKCGvldgsyNVSCLCSTDAFLGWSYDTCVSNNRCNIFSNFILNGINSGTTCSNDLLQ 305
PDEV-like_Spike_SD1-2_S1-2_S2 cd22376
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
612-1267 2.55e-104

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from Porcine epidemic diarrhea virus and related alphacoronavirus; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses, including porcine epidemic diarrhea virus (PEDV), Scotophilus bat coronavirus, and swine enteric coronavirus, among others. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1 the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411963 [Multi-domain]  Cd Length: 673  Bit Score: 346.74  E-value: 2.55e-104
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  612 ITTDVCVNYDLYGITGQGILIEVNAT-----YYNSwqnllydSSGNLYGFRDYLSNRTFLIRSC--------YSGRVSAV 678
Cdd:cd22376    5 MTLDVCTKYTIYGFKGEGIITLTNSSllggvYYTS-------DSGQLLAFKNVTSGAIYSVTPCsfsqqaayVDDDIVGV 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  679 FHANSSEPalmfrnlkcshvFNNTIlrqiQLVNYFdsYlgcvvnaYNNTASAVSTCDLTVGS-GYCVDYVTALRSRRSFT 757
Cdd:cd22376   78 ISSLSNST------------FNSTR----ELPGFF--Y-------HSNDGSNCTEPVLVYSNiGVCKSGSIGYVPSQSGQ 132
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  758 TgyrftnfepfaanlvndSIEP-VGGLyeIQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCEN 836
Cdd:cd22376  133 P-----------------KIAPmVTGN--ISIPTNFTMSIRTEYLQLYNTPVSVDCAMYVCNGNSRCKQLLTQYTSACKT 193
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  837 INAIL--------TEVNELLDTTQ--LQVAnslmngvTLSTkikdginFNVDDINFSPVLGClgsecnRASTRSAIEDLL 906
Cdd:cd22376  194 IESALqlsarlesVEVNSMLTISEeaLQLA-------TISS-------FNGGGYNFTNVLGA------SVQKRSFIEDLL 253
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  907 FDKVKLSDVGFV-QAYNNCTGGAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYR 985
Cdd:cd22376  254 FNKVVTNGLGTVdEDYKRCSNGLSVADLVCAQYYSGVMVLPGVVDAEKLHMYSASLIGGMVLGGITAAAALPFSYAVQAR 333
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  986 INGLGVTMDVLSQNQKLIASAFNNALDAIQEGFDATNSA--------------LVKIQAVVNANAEALNNLLQQLSNRFG 1051
Cdd:cd22376  334 LNYVALQTDVLQRNQQLLAESFNSAIGNITSAFESVKEAisqtsqglntvahaLTKVQDVVNSQGAALNQLTVQLQHNFQ 413
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1052 AISASLQEILSRLDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGN-GNHII 1130
Cdd:cd22376  414 AISSSIDDIYSRLDQLSADAQVDRLITGRLSALNAFVAQTLTKYTEVQASRKLAQQKVNECVKSQSQRYGFCGGdGEHIF 493
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1131 SLVQNAPYGLYFIHFSYVPTKYVTAKVSPGLCIAGDIGISPKSGYFINV-------NNSWMFTGSSYYYPEPITQNNVVV 1203
Cdd:cd22376  494 SLVQAAPQGLLFLHTVLVPGDFVNVTAIAGLCVDDEIALTLREPGVLFThevltytATEYFVSPRKMFEPRKPTVSDFVQ 573
                        650       660       670       680       690       700
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 82011698 1204 MSTCAVNYTKAPDLMLNTSTPNLPDFKEELYQWFKN-QSSVAPDLSLDYINVTFLDLQDEMNRLQ 1267
Cdd:cd22376  574 IESCVVTYVNLTSDQLPDVIPDYIDVNKTLDEILASlPNRTGPSLPLDVFNATYLNLTGEIADLE 638
HCoV-NL63-229E-like_Spike_SD1-2_S1-S2_S2 cd22375
SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) ...
612-1291 4.24e-103

SD-1 and SD-2 subdomains, the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoproteins from HCoV-NL63, HCoV-229E, and related alphacoronavirus; This group contains the SD-1 and SD-2 subdomains of the S1 subunit C-terminal domain (C-domain), the S1/S2 cleavage region, and the S2 fusion subunit of the spike (S) glycoprotein from alphacoronaviruses, including human coronaviruses (HCoVs), HCoV-NL63 and HCoV-229E. The CoV S protein is an envelope glycoprotein that plays a very important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains the coronavirus fusion machinery and is primarily alpha-helical. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-domain. The S1 C-domain also contains two subdomains (SD-1 and SD-2), which connect the S1 and S2 subunits. Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. The S2 subunit comprises the fusion peptide (FP), a second proteolytic site (S2'), followed by an internal fusion peptide (IFP) and two heptad-repeat domains (HR1 and HR2) preceding the transmembrane domain (TM). After binding of the S1 subunit RBD on the virion to its receptor on the target cell, the HR1 and HR2 domains interact with each other to form a six-helix bundle (6-HB) fusion core, bringing viral and cellular membranes into close proximity for fusion and infection. In order to catalyze the membrane fusion reaction, CoV S needs to be primed through cleavage at the S1/S2 and S2' sites. In the case of human-infecting coronaviruses such as SARS-CoV-2, HCoV-OC43, MERS-CoV, and HKU1, the spike protein contains an insertion of (R/K)-(2X)n-(R/K) (furin cleavage motif) at the S1/S2 site, which is absent in SARS-CoV and other SARS-related coronaviruses, as well as Rousettus bat coronavirus HKU9. The region modeled in this cd (SD-1 and SD-2, the S1/S2 cleavage region, and the S2 fusion subunit) plays an essential role in viral entry by initiating fusion of the viral and cellular membranes.


Pssm-ID: 411962 [Multi-domain]  Cd Length: 677  Bit Score: 343.42  E-value: 4.24e-103
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  612 ITTDVCVNYDLYGITGQGILIEVNATYYNSwqnLLYDS-SGNLYGFRDYLSNRTFLIRSCYSGRVSAVFHANSSEpALMF 690
Cdd:cd22375    5 VVLNNCTKYNIYDYSGTGVIRSSNDSFIGG---ITYTSnSGNLLGFKDVSTGTIYSITPCNPPDQVVVYQQAIVG-AMLS 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  691 RNlKCSHVFNNTIlrqiQLVNYFdsylgCVVNAYNNTASAVstcdLTVGS-GYCVD-YVTALRSRRSFTTGYRFTnfepF 768
Cdd:cd22375   81 EN-ETRYGLSNVV----ELPNFY-----YASNGTYNCTDAV----LTYSNfGICADgSIIPVRPRNVSDNGVSAI----V 142
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  769 AANLvndsiepvgglyeiQIPSEFTIGNLEEFIQTRSPKVTIDCATFVCGDYAACRQQLAEYGSFCENINAIL------- 841
Cdd:cd22375  143 TANL--------------SIPSNWTTSVQVEYLQITSTPIVVDCSTYVCNGNPRCVELLKQYTSACKTIEDALrlsarle 208
                        250       260       270       280       290       300       310       320
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  842 -TEVNELL--DTTQLQVANSLMNGvtlstkikdginfnvdDINFSPVLGCLGSECNRASTRSAIEDLLFDKVKLSDVGFV 918
Cdd:cd22375  209 sADVSSMLtfDSNAFTLANVSSFG----------------DYNLSSVLPQLPTSGSRIAGRSAIEDLLFSKVVTSGLGTV 272
                        330       340       350       360       370       380       390       400
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  919 QA-YNNCTGGAEIRDLICVQSYNGIKVLPPLLSENQISGYTLAATAASLFPPWTAAAGVPFYLNVQYRINGLGVTMDVLS 997
Cdd:cd22375  273 DAdYKSCTKGLSIADLACAQYYNGIMVLPGVADAERMAMYTGSLIGGMALGGLTSAAAIPFSLALQARLNYVALQTDVLQ 352
                        410       420       430       440       450       460       470       480
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  998 QNQKLIASAFNNALDAIQEGFDATN--------------SALVKIQAVVNANAEALNNLLQQLSNRFGAISASLQEILSR 1063
Cdd:cd22375  353 ENQKILAASFNKAMTNIVDAFTGVNdaitqtsqaiqtvaTALNKIQDVVNQQGNALNHLTSQLRQNFQAISSSIQAIYDR 432
                        490       500       510       520       530       540       550       560
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1064 LDALEAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAIEKVNECVKSQSSRINFCGNGNHIISLVQNAPYGLYFI 1143
Cdd:cd22375  433 LDTIQADQQVDRLITGRLAALNAFVSQTLTKYTEVRASRQLAQQKVNECVKSQSNRYGFCGNGTHIFSIVNAAPEGLVFL 512
                        570       580       590       600       610       620       630       640
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1144 HFSYVPTKYVTAKVSPGLCIAGDIGI---SPKSGYFINvNNSWMFTGSSYYYPEPITQNNVVVMSTCAVNYTKAPDLMLN 1220
Cdd:cd22375  513 HTVLLPTQYKDVEAWSGLCVDGVNGYvlrQPNLALYKD-GGVFRITSRVMFEPRIPTMADFVQIENCNVTFVNISRSELQ 591
                        650       660       670       680       690       700       710       720
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698 1221 TSTPNLPDFKEELYQWF-KNQSSVAPDLSLDYINVTFLDLQDEMN--------------RLQEAIKVLNQSYINLKDIGT 1285
Cdd:cd22375  592 TIVPEYVDVNKTLQELIeKLPNYTVPDLDLDQYNQTILNLTSEIStlenksaelnytvqKLQTLIDNINSTLVDLKWLNR 671

                 ....*.
gi 82011698 1286 YEYYVK 1291
Cdd:cd22375  672 VETYIK 677
CoV_Spike_S1_NTD cd21527
N-terminal domain of the S1 subunit of coronavirus Spike (S) proteins; This family contains ...
35-297 4.86e-101

N-terminal domain of the S1 subunit of coronavirus Spike (S) proteins; This family contains the N-terminal domain (NTD) of the S1 subunit of coronavirus (CoV) Spike (S) proteins from all four (A-D) lineages of betacoronaviruses, including three highly pathogenic human CoVs (HCoV) such as Middle East respiratory syndrome (MERS)-related CoV, Severe acute respiratory syndrome (SARS) CoV, and SARS-CoV-2, also known as a 2019 novel coronavirus (2019-nCoV) or COVID-19 virus. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). Most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV, use the C-domain to bind their receptors. However, some CoVs from the A lineage, such as mouse hepatitis virus (MHV) uses the NTD to bind its receptor, mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a). Bovine CoV and HCoV-OC43, also from the A lineage, recognize a sugar moiety, 5-N-acetyl-9-O-acetylneuraminic acid (Neu5,9Ac2), on cell-surface glycoproteins or glycolipids; this binding is also through the S1 NTD. The S1 NTD has also been the target for neutralizing antibodies, including human antibody CDC2-A2, and murine antibodies G2 and 5F9, which target MERS-CoV NTD. In addition, the S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394949  Cd Length: 268  Bit Score: 322.89  E-value: 4.86e-101
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   35 SISSEVVDVTNGLGTFYVLDRVYLNTTLLLNGYYPISGATFRNMALKGTRLLSTLWFKPPFLSPFNDGIFAKVKNSRFSK 114
Cdd:cd21527    1 KISTHTSDVSKGLGTYYPDDRVYSNTTLLLQGLFPYDGSNFTNYALKGSHALGTLWFYPPFVSPFNNGIFVKVKNTKNST 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  115 DGVIYSEFPAITIGSTFVNTSYSIVVEPHtslingNLQGLLQISVCQYTMCEYPHTICHPNL-GNQRIELWHYDTDVVSC 193
Cdd:cd21527   81 SATIYSEYPAIVFGSTFGNTSYTVVIQPD------NGGTLLEASACQYEMCEYNATICVPKTdGSDGNYSWHIDSNAFNC 154
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  194 LYRRNFTYDVNADYLYFHFYQEGGTFYAYFTDT----GFVTKFLFKLYLGTVLSHYYVMPLTCNSALS------LEYWVT 263
Cdd:cd21527  155 TFEYNFTYNVNADLLYFGFYQEDGTLYAYYSDYvdlyGGPLKFLFSLPLGDNLTNYYVIPLTCRSIQSsdrkfaAAYYVT 234
                        250       260       270
                 ....*....|....*....|....*....|....
gi 82011698  264 PLTTRQFLLAFDQDGVLYHAVDCASDFMSEIMCK 297
Cdd:cd21527  235 YLTPRTFLLNFDENGVITNAVDCSSNFLSELKCS 268
bCoV_S1_N pfam16451
Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal ...
42-330 9.84e-83

Betacoronavirus-like spike glycoprotein S1, N-terminal; This entry represents the N-terminal domain of the betacoronavirus-like trimeric spike glycoprotein. The distal S1 subunit of the coronavirus spike protein is responsible for receptor binding. S1 contains two domains; an N-terminal galectin-like domain (NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Either the S1 NTD or S1 RBD, or occasionally both, are involved in binding to host receptors. S1 NTD is located on the side of the spike trimer and mainly recognizes sugar receptors. For many betacoronaviruses (b-CoVs), for example mouse hepatitis virus (MHV), the RBD is located in the NTD. The structure of the MHV S1 NTD showed the same fold as human galectins (galactose-binding lectin), however it does not bind any sugar; instead, it binds to the carcinoembryonic antigen cell-adhesion molecule CEACAM1) through protein-protein interactions. All three CEACAM21a-binding sites in MHV spikes can be fully occupied by CEACAM1a. It has been shown that CEACAM1a binding to the MHV spike weakens the interactions between S1 and S2 and facilitates the proteolysis of the spike protein and dissociation of S1. The homologous bovine CoV (BCov) S1 NTD also possesses a galectin fold but binds to sialic acid-containing moieties on host cell membranes, as does the NTD of three other group A b-Covs, namely human CoV (HCoV) OC43, avian b-CoV, and infectious bronchitis virus (IBV). Despite the S1 NTD of human respiratory b-CoV HKU1 being highly homologous to the NTDs of MHV and bovine CoV, it does not bind to either sugar or human carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) and the RBD is found instead in the S1 RBD domain.


Pssm-ID: 465119  Cd Length: 296  Bit Score: 273.13  E-value: 9.84e-83
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698     42 DVTNGLGTFYVLDRVYLNTTLLLNGYYPISGATFRNMALKGTRLLSTLWFKPPFLsPFNDGIFAKVKNSRFSKDGVIYSE 121
Cdd:pfam16451    1 DVSKADGTYYLPDRVYSNTTTLRQGLFPKQGDNVTNYVYSPAHHCGKRNFSTPFL-PFGDGIFVHIGNASNATGGRIISE 79
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    122 FPAITIGSTFVNTSYSIVVEPhtslinGNLQGLLQISVCQYTMCEYPHTICHPNLGNQRIE-LWHYDTDVVSCLYRRNFT 200
Cdd:pfam16451   80 PPAFVFGSTFGNTSHTLIIAP------DSCQTNLTILVCNFTLCANPVTACRWGAGNYNANnSLVYFKNAINCTFNRTYN 153
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    201 YDVNADYLYFHFYQEGGTFYAYFT------DTGFVTKFLF-KLYLGTVLSHYYVMPLTCNSA-----LSLEYWVTPLTTR 268
Cdd:pfam16451  154 ITFDTSLIYFGFKQQDGGFHIYYSywlpdlDSGPPTLFPFaTLPLGINITYFQVIPSSIRSTqncrrANAAYYVAPLKPS 233
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|..
gi 82011698    269 QFLLAFDQDGVLYHAVDCASDFMSEIMCKTSSITPPTGVYELNGYTVQPVATVYRRIPDLPN 330
Cdd:pfam16451  234 TFLLDFDVNGYITNAVDCSFDPLSELKCSTGSFEPDTGVYSTSSYRAQPVGSVYVRQPNVTC 295
CoV_Spike_S1_RBD cd21470
receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; This family ...
315-482 3.16e-58

receptor-binding domain of the S1 subunit of coronavirus spike (S) proteins; This family contains the receptor-binding domain (RBD) of the S1 subunit of coronavirus (CoV) spike (S) proteins from three highly pathogenic human coronaviruses (CoVs), including Middle East respiratory syndrome coronavirus (MERS-CoV), Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), and SARS coronavirus 2 (SARS-CoV-2), also known as a 2019 novel coronavirus (2019-nCoV), as well as S proteins from related coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2, SARS-CoV and MERS-CoV use the C-domain to bind their receptors. MHV uses mouse carcinoembryonic antigen related cell adhesion molecule 1a (mCEACAM1a) as the receptor, and the receptors for SARS-CoV and MERS-CoV are human angiotensin-converting enzyme 2 (ACE2) and human dipeptidyl peptidase 4 (DPP4), respectively. Recent studies found that the RBD of SARS-CoV-2 S protein binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. Moreover, SARS-CoV-2 RBD exhibited significantly higher binding affinity to the ACE2 receptor than SARS-CoV RBD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs.


Pssm-ID: 394823  Cd Length: 171  Bit Score: 198.09  E-value: 3.16e-58
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  315 VQPVATVYRRIPDLPNCDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITIDK 394
Cdd:cd21470    1 VKPSGSVVRRPNNTPLCDFSEWLNATSVPSVYNWERKVFSNCNFNLSKLLSLFSVDSFTCNGISPAKIAGLCFSSITVDK 80
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  395 FAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPAANVSVT-HYNPSSWNRRYGFNNQSF--GSRGLHDAVYSQ 471
Cdd:cd21470   81 FAIPLSRKSDLQPGSAGFIQDYNYKIDFDNTSCQLAYNLPANNATITkNHDYVYIQKFLGWSTDGCtsGDQCQIFFNISF 160
                        170
                 ....*....|.
gi 82011698  472 QCFNTPNTYCP 482
Cdd:cd21470  161 QYGNASGTVCS 171
bCoV_S1_RBD pfam09408
Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor ...
344-484 1.08e-37

Betacoronavirus spike glycoprotein S1, receptor binding; This entry represents the receptor binding domain (S1 RBD) of the betacoronavirus spike glycoprotein. The spike glycoprotein is arranged in trimers on the surface of the viral membrane and is essential for viral entry. The spike protein is translated as a large polypeptide that is subsequently cleaved to the distal S1, responsible for receptor binding, and the membrane-anchored S2 responsible for membrane fusion. The coronavirus (SARS-CoV) S1 subunit is composed of two distinct domains: an N-terminal domain (S1 NTD) and a receptor-binding domain (S1 RBD) also referred to as the S1 CTD or domain B. Each of these domains have been implicated in binding to host receptors. However, most coronaviruses are not known to utilize both the S1 NTD and S1 RBD for viral entry. SARS-CoV makes use of its S1 RBD to bind to the human angiotensin-converting enzyme 2 (ACE2) as its host receptor.


Pssm-ID: 462789  Cd Length: 156  Bit Score: 138.79  E-value: 1.08e-37
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698    344 SPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITIDKFAIPNSRKVDLQVGKSGYLQSFNYKIDTA 423
Cdd:pfam09408    2 SPANWERKTFSNCNFDFSVLLSLLQVSSFKCYGVSPSKLADMCYGSVTIDYFAIPETHKSNLQPGSPGAISKYNYKLPDD 81
                           90       100       110       120       130       140
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 82011698    424 VSSCQLyyslpaanvsvtHYNPSSWNrRYGFNNQSFGSrglhdavysqqcFNTPNTYCPCR 484
Cdd:pfam09408   82 FYGCVL------------AFNVNANT-NYAFADNYPYR------------YIKPGQYQPCN 117
MERS-like_CoV_Spike_S1_RBD cd21479
receptor-binding domain of the S1 subunit of the Spike (S) protein from Middle East ...
315-495 7.57e-20

receptor-binding domain of the S1 subunit of the Spike (S) protein from Middle East respiratory syndrome coronavirus; This family contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from the human coronavirus that causes Middle East Respiratory Syndrome (MERS-CoV) and related coronaviruses from animals. MERS-CoV causes severe pulmonary disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including MERS-CoV use the C-domain to bind their receptors. MERS-CoV use human dipeptidyl peptidase 4 (DPP4), also called CD26, as its receptor. It binds DPP4 through the RBD of its S1 subunit and then fuses viral and host membranes through its S2 subunit. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs including MERS-CoV.


Pssm-ID: 394826  Cd Length: 216  Bit Score: 89.76  E-value: 7.57e-20
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  315 VQPVATVYRRiPDLPNCDIEAWLnsKTVSSPL-NWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITID 393
Cdd:cd21479    1 AKPRGTFIEQ-AEGVECDFSPLL--KGTPPQVyNFKRLVFTNCNYNLTKLLSLFQVDEFSCHQISPSALATGCYSSLTVD 77
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  394 KFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYSLPaANVSVThyNPSSwnrrYGFNNQSFGSrglhDAVYSQQC 473
Cdd:cd21479   78 YFAYPLSMKSYLQPGSAGPIVQFNYKQDFSNPTCRILATVP-ANLTIT--KPSN----YSYITKCSRL----TGDGKNPQ 146
                        170       180
                 ....*....|....*....|..
gi 82011698  474 FNTPNTYCPCRTSQCIGGAGTG 495
Cdd:cd21479  147 YVNPGQYTPCLCFSPSGLAEDG 168
bat_HKU4-like_Spike_S1_RBD cd21487
receptor-binding domain of the S1 subunit of the Spike (S) protein from Tylonycteris bat ...
326-484 3.13e-18

receptor-binding domain of the S1 subunit of the Spike (S) protein from Tylonycteris bat coronavirus HKU4 and similar proteins; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from Tylonycteris bat coronavirus HKU4 and other Middle East Respiratory Syndrome (MERS)-related coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including human MERS-CoV that is phylogenetically closely related to bat CoV HKU4 use the C-domain to bind their receptors. HKU4 is able to bind the MERS-CoV receptor, human dipeptidyl peptidase 4 (DPP4), also called CD26. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs including MERS-CoV, and most likely, bat CoV HKU4.


Pssm-ID: 394834  Cd Length: 219  Bit Score: 85.03  E-value: 3.13e-18
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  326 PDLPNCDIEAWLNSkTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITIDKFAIPNSRKVDL 405
Cdd:cd21487   11 PNATECDFSPMLTG-VAPQVYNFKRLVFSNCNYNLTKLLSLFAVDEFSCNGISPDAIARGCYSTLTVDYFAYPLSMKSYI 89
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 82011698  406 QVGKSGYLQSFNYKIDTAVSSCQLYYSLPaANVSVThyNPSSwnrrYGFNNQSFGSRGLHDAVYSQQCFNtPNTYCPCR 484
Cdd:cd21487   90 RPGSAGNIPLYNYKQSFANPTCRVMASVP-ANVTIT--KPEA----YGYISKCSRLTGDNQHIETPLYIN-PGEYSICR 160
human_MERS-CoV_Spike_S1_RBD cd21486
receptor-binding domain of the S1 subunit of the Spike (S) protein from human Middle East ...
331-483 5.12e-15

receptor-binding domain of the S1 subunit of the Spike (S) protein from human Middle East respiratory syndrome coronavirus; This group contains the receptor-binding domain (RBD) of the S1 subunit of the spike (S) protein from the human coronavirus that causes Middle East Respiratory Syndrome (MERS-CoV). MERS-CoV causes severe pulmonary disease in humans. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including MERS-CoV use the C-domain to bind their receptors. MERS-CoV use human dipeptidyl peptidase 4 (DPP4), also called CD26, as its receptor. It binds DPP4 through the RBD of its S1 subunit and then fuses viral and host membranes through its S2 subunit. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for most CoVs including MERS-CoV.


Pssm-ID: 394833  Cd Length: 219  Bit Score: 75.55  E-value: 5.12e-15
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  331 CDIEAWLnSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITIDKFAIPNSRKVDLQVGKS 410
Cdd:cd21486   16 CDFSPLL-SGTPPQVYNFKRLVFTNCNYNLTKLLSLFSVNDFTCSQISPAAIASNCYSSLILDYFSYPLSMKSDLSVSSA 94
                         90       100       110       120       130       140       150
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 82011698  411 GYLQSFNYKIDTAVSSCQLYYSLPAANVSVTHynpsswNRRYGFNNQSfgSRGLHDAVYSQQCFNTPNTYCPC 483
Cdd:cd21486   95 GPISQFNYKQSFSNPTCLILATVPHNLTTITK------PLKYSYINKC--SRLLSDDRTEVPQLVNANQYSPC 159
SARS-CoV-like_Spike_S1_NTD cd21624
N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory ...
98-298 1.11e-10

N-terminal domain of the S1 subunit of the Spike (S) protein from Severe acute respiratory syndrome coronavirus and related betacoronaviruses in the B lineage; This subfamily contains the N-terminal domain (NTD) of the S1 subunit of the Spike (S) proteins from betacoronaviruses in the sarbecovirus subgenera (B lineage), including the highly pathogenic human coronavirus (CoV), Severe acute respiratory syndrome (SARS) CoV, and SARS-CoV-2, also known as a 2019 novel coronavirus (2019-nCoV) or COVID-19 virus. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). Most CoVs, including SARS-CoV-2 and SARS-CoV, use the C-domain to bind their receptors. The S1 NTD contributes to the Spike trimer interface.


Pssm-ID: 394950  Cd Length: 280  Bit Score: 63.89  E-value: 1.11e-10
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698   98 PFNDGIFAKVknsrFSKDGVIysefPAITIGSTFVNTSYS-IVVEPHTSLIngnlqgllqISVCQYTMCEYPHTICHPNl 176
Cdd:cd21624   72 PFGDGVYFAA----TEKSNVV----RGWIFGSTFDNTSQSaIIVNNGTHII---------IRVCNFQLCKNPMFAVSKP- 133
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  177 gNQRIELWHYdTDVVSCLYRR--------NFTYDVNADYLYFH-FYQEGGTFYAYFT----------DTGF-VTKFLFKL 236
Cdd:cd21624  134 -GTQTNSWIY-SNAFNCTYEYvsqsfqldVSEKNGNFKHLREFvFKNVDGFLKVYHGyqpinvvrglPSGFsVLKPIFKL 211
                        170       180       190       200       210       220       230
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 82011698  237 YLGTVLSHYYVMP----------LTCNSAlsleYWVTPLTTRQFLLAFDQDGVLYHAVDCASDFMSEIMCKT 298
Cdd:cd21624  212 PLGINITNFRVVLtmfspaqsnwTAGNAA----YYVGYLKPTTFMLKFDENGTITDAVDCSQDPLAELKCTL 279
CoV_S1_C pfam19209
Coronavirus spike glycoprotein S1, C-terminal; This entry represents a domain found at the ...
615-672 3.44e-10

Coronavirus spike glycoprotein S1, C-terminal; This entry represents a domain found at the C-terminus of the Coronavirus S1 protein. It is found across a range of alpha, beta and gamma coronaviruses. This small all beta stranded domain is known as subdomain 2 in the structure of the porcine epidemic diarrhea virus spike protein.


Pssm-ID: 437047 [Multi-domain]  Cd Length: 57  Bit Score: 56.86  E-value: 3.44e-10
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|....*....
gi 82011698    615 DVCVNYDLYGITGQGILIEVNATYYNswqNLLY-DSSGNLYGFRDYLSNRTFLIRSCYS 672
Cdd:pfam19209    1 NVCTDYTIYGITGTGVIRETNSTIPS---GLYYtSSSGDLLGFKNSTTGTVYSVTPCVS 56
SARS-CoV-2_Spike_S1_RBD cd21480
receptor-binding domain of the S1 subunit of severe acute respiratory syndrome coronavirus 2 ...
315-432 3.67e-08

receptor-binding domain of the S1 subunit of severe acute respiratory syndrome coronavirus 2 Spike (S) protein; This group contains the receptor-binding domain of the S1 subunit of the spike (S) protein from highly pathogenic human virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV). The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While RBD of mouse hepatitis virus (MHV) is located at the NTD, most of other CoVs, including SARS-CoV-2 use the C-domain to bind their receptors. Recent studies found that the receptor-binding domain (RBD) of SARS-CoV-2 S protein binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. Moreover, SARS-CoV-2 RBD exhibited significantly higher binding affinity to the ACE2 receptor than SARS-CoV RBD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for SARS-CoV-2 and most CoVs.


Pssm-ID: 394827  Cd Length: 223  Bit Score: 55.49  E-value: 3.67e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  315 VQPVATVYRrIPDLPN-CDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITID 393
Cdd:cd21480    2 VQPTESIVR-FPNITNlCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYAD 80
                         90       100       110
                 ....*....|....*....|....*....|....*....
gi 82011698  394 KFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSCQLYYS 432
Cdd:cd21480   81 SFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWN 119
SARS-CoV_Spike_S1_RBD cd21481
receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related ...
324-454 9.92e-08

receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related coronavirus Spike (S) protein; This group contains the receptor-binding domain of the S1 subunit of the spike (S) protein from severe acute respiratory syndrome-related coronavirus (SARS-CoV) and similar coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV use the C-domain to bind their receptors. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for SARS-CoV and most CoVs.


Pssm-ID: 394828  Cd Length: 222  Bit Score: 54.31  E-value: 9.92e-08
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  324 RIPDLPN-CDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITIDKFAIPNSRK 402
Cdd:cd21481   10 RFPNITNlCPFGEVFNATKFPSVYAWERKKISNCVADYSVLYNSTFFSTFKCYGVSATKLNDLCFSNVYADSFVVKGDDV 89
                         90       100       110       120       130
                 ....*....|....*....|....*....|....*....|....*....|..
gi 82011698  403 VDLQVGKSGYLQSFNYKIDTAVSSCQLYYSlpAANVSVThyNPSSWNRRYGF 454
Cdd:cd21481   90 RQIAPGQTGVIADYNYKLPDDFMGCVLAWN--TRNIDAT--STGNYNYKYRY 137
SARS-CoV-like_Spike_S1_RBD cd21477
receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related ...
315-427 2.44e-06

receptor-binding domain of the S1 subunit of severe acute respiratory syndrome-related coronavirus Spike (S) protein and similar proteins; This subfamily contains the receptor-binding domain of the S1 subunit of coronavirus (CoV) spike (S) proteins from highly pathogenic human virus, severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV), SARS coronavirus 2 (SARS-CoV-2), also known as 2019 novel coronavirus (2019-nCoV), and other SARS-like coronaviruses. The CoV S protein is an envelope glycoprotein that plays the most important role in viral attachment, fusion, and entry into host cells, and serves as a major target for the development of neutralizing antibodies, inhibitors of viral entry, and vaccines. It is synthesized as a precursor protein that is cleaved into an N-terminal S1 subunit (~700 amino acids) and a C-terminal S2 subunit (~600 amino acids) that mediates attachment and membrane fusion, respectively. Three S1/S2 heterodimers assemble to form a trimer spike protruding from the viral envelope. The S1 subunit contains a receptor-binding domain (RBD), while the S2 subunit contains a hydrophobic fusion peptide and two heptad repeat regions. S1 contains two structurally independent domains, the N-terminal domain (NTD) and the C-terminal domain (C-domain). Depending on the virus, either the NTD or the C-domain can serve as the receptor-binding domain (RBD). While the RBD of mouse hepatitis virus (MHV) is located at the NTD, most CoVs, including SARS-CoV-2 and SARS-CoV use the C-domain to bind their receptors. Recent studies found that the receptor-binding domain (RBD) of SARS-CoV-2 S protein binds strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors. Moreover, SARS-CoV-2 RBD exhibited significantly higher binding affinity to the ACE2 receptor than SARS-CoV RBD. Due to the key role of the S protein RBD in viral attachment, it is the major target for antibody-mediated neutralization. This model corresponds to the S1 subunit C-domain that serves as the RBD for SARS-CoV, SARS-CoV-2, and most CoVs.


Pssm-ID: 394824  Cd Length: 205  Bit Score: 49.82  E-value: 2.44e-06
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  315 VQPVATVYRrIPDLPN-CDIEAWLNSKTVSSPLNWERKIFSNCNFNMGRLMSFIQADSFGCNNIDASRLYGMCFGSITID 393
Cdd:cd21477    2 VSPTTEVVR-FPNITNlCPFDKVFNATRFPSVYAWERTKISDCVADYTVLYNSTSFSTFKCYGVSPSKLIDLCFTSVYAD 80
                         90       100       110
                 ....*....|....*....|....*....|....
gi 82011698  394 KFAIPNSRKVDLQVGKSGYLQSFNYKIDTAVSSC 427
Cdd:cd21477   81 TFLIRGSEVRQVAPGQTGVIADYNYKLPDDFTGC 114
COG4192 COG4192
Signal transduction histidine kinase regulating phosphoglycerate transport system [Signal ...
998-1106 7.53e-03

Signal transduction histidine kinase regulating phosphoglycerate transport system [Signal transduction mechanisms];


Pssm-ID: 443346 [Multi-domain]  Cd Length: 640  Bit Score: 40.83  E-value: 7.53e-03
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 82011698  998 QNQKLIASAFNNALDAIQEgFDATNSALVKIQAVVNANAEALNNLLQQLS----NRFgAISASLQEILSRLDAL------ 1067
Cdd:COG4192   81 TERSQLRNQLNTQLADIEE-LLAELEQLTQDAGDLRAAVADLRNLLQQLDslltQRI-ALRRRLQELLEQINWLhqdfns 158
                         90       100       110
                 ....*....|....*....|....*....|....*....
gi 82011698 1068 EAKAQIDRLINGRLTALNAYVSQQLSDSTLVKFSAAQAI 1106
Cdd:COG4192  159 ELTPLLQEASWQQTRLLDSVETTESLRNLQNELQLLLRL 197
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH